PRPL 10-K & 10-Q changes, risk factors and insider trading
Purple Innovation, Inc. · Nasdaq · Household Furniture · CIK 1643953 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “There is substantial doubt about our ability to continue as a going concern, and we may need additional financing to execute our business plan, to fund our operations and to continue as a going concern.”
New heading “Changes in U.S. trade policy including the impact of tariffs are having and may continue to have a material adverse effect on our business and results of operations.”
Removed heading “We may not realize all the intended benefits of our Restructuring Plan and other cost-saving initiatives, which could adversely affect our results of operations and our financial condition.”
Removed heading “There is continued risk of ownership change under Code Section 382.”
Removed heading “The NOL Protective Charter Amendment and the NOL Rights Plan may potentially adversely affect the market for, and negatively impact the value of, our Common Stock.”
Removed heading “The NOL Protective Charter Amendment and the NOL Rights Plan may have an anti-takeover effect.”
Largest changes
In addition, on March 12, 2025,see in full comparisonwethe Loan Parties, entered intoanthe First Amendment to the Amended and Restated Credit Agreement (the “2025AmendmentAmendment,” and the Amended and Restated Credit Agreement as so amended, the “Amended A&R Credit Agreement) with CCP and Blackwell Partners LLC – Series A (“Blackwell”) (collectively the “2025 Lenders”), pursuant to which the 2025 Lenders agreed to provide us with an incremental term loan of $19.0million.million pursuant to Section 2.18 of the Amended and Restated Credit Agreement. On May 2, 2025, the Loan Parties entered into a Second Amendment to the Amended and Restated Credit Agreement (the “ Second 2025Amendment”), $20.0 million pursuant to Section 2.18 of the Amended A&R Credit Agreement. On March 24, 2026, the Loan Parties entered into a Third Amendment to the Amended and Restated Credit Agreement (the “Third Amendment”), which revised the maturity date under the Amended and Restated Credit Agreement from December 31, 2026, to April 30, 2027, and waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. The 2025 Amendment also amended the Amended A&Rand RestatedCredit Agreement to (i) provide for an additional term loan from the 2025 Term Loan Lenders (as defined in the 2025 Amendment) in an aggregate amount not to exceed $20.0 million, subject to the approval of the Required Lenders in their discretion, (ii) provide for the payment of substantial make-whole payments in the event we prepay the loans prior to their maturity, and (iii) provide that the incremental term loan will be senior in right of repayment to the initial term loan.
“There is substantial doubt about our ability to continue as a going concern, and we may need additional financing to execute our business plan, to fund our operations and to continue as a going concern.”see in full comparison
“We may not realize all the intended benefits of our Restructuring Plan and other cost-saving initiatives, which could adversely affect our results of operations and our financial condition.”see in full comparison
“Changes in U.S. trade policy including the impact of tariffs are having and may continue to have a material adverse effect on our business and results of operations.”see in full comparison
“In 2024, we implemented our Restructuring Plan to consolidate our Utah manufacturing operations into our McDonough, Georgia plant, and we plan to undertake further cost-saving initiatives in 2025. However, the remaining costs under our Restructuring Plan may exceed estimates, and we may not achieve all the expected financial benefits or savings. Relocating equipment to Georgia and expanding our workforce there could be challenging. Replacing experienced Utah employees with less experienced Georgia staff may lead to a loss of knowledge, lower productivity, and decreased efficiency and quality. …”see in full comparison
“These actions could adversely affect our operations, relationships with suppliers and partners, and our ability to execute our strategy, which would have a material adverse impact on our business, results of operations and financial condition and could ultimately require us to consider broader restructuring alternatives if liquidity becomes insufficient.”see in full comparison
Full comparison: every changed paragraph (63)
On
January 23, 2024, to refinance existing obligations, wePurple LLC, Purple Inc. and Intellibed (collectively, the “Loan Parties”)
entered into a Second Amendment to Term Loan Agreement (the “Second Amendment”)
and an Amendedamended and Restatedrestated Creditcredit Agreementagreement (the “Amended and Restated Credit Agreement”), which amended and restated
the then existing term loan agreement (“Term Loan Agreement”), with Coliseum Capital Partners, L.P.Partners (“CCP”),
Blackwell Partners LLC – Series A (“Blackwell”), Harvest Small Cap Partners Master, Ltd.(“Harvest Master”),
Harvest Small Cap Partners, L.P. (“Harvest Partners”), and HSCP Strategic IV, L.P.other
lenders (“HSCP” and together with CCP,
Blackwell, Harvest Master, and Harvest Partners,collectively, the “Lenders”). and Delaware Trust Company, as administrative agent. Upon entry into the Amended and
Restated Credit Agreement,
we received a term loan in the amount of $61.0 million. The Amended and Restated Credit Agreement imposes various
affirmative and negative
covenants, including covenants regarding dispositions of property, investments, forming or acquiring subsidiaries,
business combinations
or acquisitions, incurrence of additional indebtedness, paying dividends or making distributions and transactions
with affiliates, among
other customary covenants.
These restrictions may prevent
us from taking actions that we believe would be in the best interests of the business and complicate our ability to execute our business
strategy or compete with less restricted companies. If we fail to comply with the covenants under the Amended and Restated Credit
Agreement, we may need to seek future amendments or waivers and/or alternative liquidity sources, such as subordinated debt, which may
not be favorable or available. Before taking any action requiring a waiver under the Amended and Restated Credit Agreement, we must first
obtain approval from the Lenders, which may cause us to incur additional costs and may not be granted. Non-compliance could lead to defaults,
which could materially adversely affect our financial condition and results of operations, including possible acceleration of our debtdebt,
and, as well as other cross-defaulting debt obligations. Additionally, defaults could significantly impair our ability to secure alternative
financing and limit our business strategies. Our compliance with these covenants will depend on successfully implementing our business
strategy,strategies, as breaches could lead to defaults and acceleration of our debt, potentially forcing us into bankruptcy or liquidation.
In addition, on March 12,
2025, wethe Loan Parties, entered into anthe First Amendment to the Amended and Restated Credit Agreement (the “2025 AmendmentAmendment,”
and the Amended and Restated Credit Agreement as so amended, the “Amended A&R Credit Agreement) with CCP and Blackwell Partners
LLC – Series A (“Blackwell”) (collectively the “2025 Lenders”), pursuant to which
the 2025 Lenders agreed
to provide us with an incremental term loan of $19.0 million.million pursuant to Section 2.18 of the Amended and Restated Credit Agreement. On
May 2, 2025, the Loan Parties entered into a Second Amendment to the Amended and Restated Credit Agreement (the “ Second 2025Amendment”),
$20.0 million pursuant to Section 2.18 of the Amended A&R Credit Agreement. On March 24, 2026, the Loan Parties entered into a Third
Amendment to the Amended and Restated Credit Agreement (the “Third Amendment”), which revised the maturity date under the
Amended and Restated Credit Agreement from December 31, 2026, to April 30, 2027, and waived certain requirements and events of default
relating to the going concern qualification in our December 31, 2025 financial statements. The 2025 Amendment also amended the Amended
A&R and Restated
Credit Agreement to (i) provide for an additional term loan from the 2025 Term Loan Lenders (as defined in the 2025 Amendment)
in an aggregate
amount not to exceed $20.0 million, subject to the approval of the Required Lenders in their discretion, (ii) provide
for the payment
of substantial make-whole payments in the event we prepay the loans prior to their maturity, and (iii) provide that the
incremental term
loan will be senior in right of repayment to the initial term loan.
Under the Amended and Restated
Credit Agreement, we have mandatory prepayment obligations, including upon certain asset dispositions, equity issuances, debt incurrences
and extraordinary receipts of cash. As amended by the 2025 Amendment, we may be required to make substantial “make-whole”
payments to the Lenders. If required to prepay or pay such make-whole payments, we may lack the liquidity to do so, resulting in default.
Prepayments, including make-whole payments, would also divert resources from operating expenses, potentially harming relationships with
suppliers, hindering growth strategies, and jeopardizing our business continuity. In addition, such payments could result in holders of
our Class A Stockcommon stock not receiving any consideration in a sale of our business, or if we were to liquidate, dissolve, or wind-up,
either either
voluntarily or involuntarily.
There is substantial doubt about our ability to continue as a going concern, and we may need additional financing to execute our business plan, to fund our operations and to continue as a going concern.
Our independent registered public accounting firm has expressed in its auditors’ report on our 2025 financial statements, included in this Annual Report on Form 10-K, an emphasis of matter paragraph relating to our ability to continue as a “going concern,” meaning that our recurring losses from operations and negative cash flows from operations raise substantial doubt regarding our ability to continue as a going concern. We have prepared our financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Our financial statements do not include any adjustment to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.
Even with our current sources of capital, we may need to raise additional funds to support operations and our business initiatives, and such funding may not be available in sufficient amounts or on acceptable terms to us, or at all. If we are unable to raise additional capital when needed or on acceptable terms, we may be required to:
These actions could adversely affect our operations, relationships with suppliers and partners, and our ability to execute our strategy, which would have a material adverse impact on our business, results of operations and financial condition and could ultimately require us to consider broader restructuring alternatives if liquidity becomes insufficient.
We
have experienced recurring operating losses and negative cash flows and may continue to generate operating losses and consume significant
cash resources in the future. For the years ended December 31, 2024,2025, and 2023,2024, we had negative cash flow from operating activities of
$18.0$33.8 million and $54.7$17.9 million, respectively. As of December 31, 2024,2025, we had unrestricted cash and cash equivalents of $29.0$24.3 million
and borrowings of $70.7$111.3 million under our Amended and Restated Credit Agreement (as defined below),Agreement, which pursuant to the Third Amendment will become due
on December
31,April 2026.30, 2027.
On
March 12, 2025, we borrowed an additional $19.0 million under the Amended and Restated Credit Agreement pursuant to the 2025 Amendment.
On May 2, 2025, we borrowed an additional $20 million under the Amended and Restated Credit Agreement, pursuant to the Second 2025 Amendment.
Pursuant to the Third Amendment
(as definedthese below), whichamounts will also become due on DecemberApril 31,30, 2026.2027. The 2025 Amendment (as defined below) also added certain make-whole payments
payments with respect to our borrowings under the Amended and Restated Credit Agreement, which would require substantial payments in connection
with certain pre-payments or refinancing of our outstanding borrowings.
In
connection with the preparation of our 20242025 financial statements, we undertook a going concern assessment and concluded the Companywe will
have sufficient liquidity for its operations for at least one year from the date thesethose consolidated financial statements arewere issued.
However, However,
there can be no assurance that we will be able to maintain the liquidity necessary to fund our long-term operations and growth
strategies, strategies,
or repay our debt obligations when due. As a result, we may need to secure additional sources of liquidity to fund our long-term
operating operating
activities and capital expenditures. However, there can be no assurance that we will be able to obtain additional financing
as needed
on terms favorable to us, or at all. If we fail to meet liquidity and capital requirements, we may need to scale back or halt
our growth
plans, risking slower growth, losing suppliers, failing to meet customer demands, and losing employees. We may also need to
restructure restructure
our obligations or pursue other measures to address any liquidity deficiency. In addition, future equity or debt financings
are likely to be dilutive to our existing stockholders, including through the issuance of common stock purchase warrants.
Under the Amended and Restated Credit Agreement, we can request additional loans, but the Lenders may deny requests, limiting our access to future funds and adversely affecting our liquidity, financial condition and results of operations. As a condition to providing future funds, the Lenders may require other revisions to the Amended and Restated Credit Agreement, such as increasing prepayment or make-whole payments or including additional restrictive covenants, which could adversely affect our business and financial condition.
Future
equity or debt financings may involve issuing securities likely to be dilutive to our existing stockholders, such as warrants, as we did
on January 23, 2024 when we issued to the Lenders, as partial consideration for their entering into the Amended and Restated Credit Agreement,
warrants (the “2024 Warrants”) to purchase 20.0 million shares of our Common Stock (approximately 19% of our currently outstanding
Common Stock) at a price of $1.50 per share, subject to certain adjustments. In addition, on March 12, 2025, we issued to the Lenders,
as partial consideration for their entering into the 2025 Amendment, warrants (the “2025 Warrants” and together with the 2024
Warrants, the “Warrants”) to purchase 6.2 million shares of our Common Stock (approximately 6% of our currently outstanding
Common Stock) at a price of $1.50 per share, subject to certain adjustments. The exercise of such warrants and/or any additional similar
securities in the future would dilute the value and amount of our Common Stock. Similarly, any new securities we may issue may carry preferences,
superior voting rights, or additional terms that could adversely affect shareholders of our Common Stock. Future capital raising efforts
may incur substantial costs, such as investment banking, legal, and accounting fees, and could lead to non-cash expenses that negatively
impact our financial condition.
We
may not realize all the intended benefits of our Restructuring Plan and other cost-saving initiatives, which could adversely affect our
results of operations and our financial condition.
In
2024, we implemented our Restructuring Plan to consolidate our Utah manufacturing operations into our McDonough, Georgia plant, and we
plan to undertake further cost-saving initiatives in 2025. However, the remaining costs under our Restructuring Plan may exceed estimates,
and we may not achieve all the expected financial benefits or savings. Relocating equipment to Georgia and expanding our workforce there
could be challenging. Replacing experienced Utah employees with less experienced Georgia staff may lead to a loss of knowledge, lower
productivity, and decreased efficiency and quality. Manufacturing in a single U.S. region could increase our distribution costs. Consolidating
plants may cause disruptions in our inventory and raw material supply. We may not fully sublease our Utah facilities, impacting our financial
condition. The Restructuring Plan, as well as past and future restructurings, including workforce reductions, could harm employee morale,
disrupt business operations, result in the loss of institutional knowledge, damage our reputation, and impair our ability to attract skilled
talent, negatively affecting the business.
In
addition, we plan to implement additional cost savings measures in 2025 beyond those implemented pursuant to our 2024 Restructuring Plan.
We may not achieve the expected financial benefits or savings from these additional cost savings measures, which could further adversely
affect our results of operations and financial condition. Additionally, such cost saving measures may adversely affect our ability to
generate additional revenue in the future.
Coliseum Capital Management, LLC (“Coliseum”) is our largest stockholder and Lender, and exercises substantial control over our Board of Directors (“Board”) composition, management team members and strategies.
As reported by Coliseum in
its Schedule 13D/A filed on JanuaryMay 23,6, 2024,2025, Coliseum Capital Management LLC (“Coliseum”) beneficially owns 58.561.1 million
shares of Common Stock (which includes 46.9 million shares
of Common Stock currently owned and 11.614.2 million shares of Common Stock that
could be acquired upon exercise of its Warrantswarrants). Coliseum
will only have the right to exercise its Warrantswarrants to the extent that it (together
with its affiliates) would not beneficially own in excess
of 49.9% of the shares of Common Stock outstanding immediately after such exercise
(the “Beneficial Ownership Cap”). In addition,
as of December 31, 2025, Coliseum holds $81.8 million of our debt, which represents 64.6% of all our debt.
In
2022, Coliseum delivered to us an unsolicited bid to acquire the remaining outstanding shares of our Common Stock, submitted a notice
of its intent to nominate a slate of directors, which slate would have constituted a majority of the Board, and filed a lawsuit challenging
our issuance of a dividend of shares of preferred stock (the “Action”). On April 19, 2023, Coliseum and the Company entered
into a cooperation agreement (the “Cooperation Agreement”) settling the Action, which included among other items the appointment
of certain new directors and agreement to certain standstill provisions, as discussed further in Note 16 – Related Party Transactions
Coliseum Capital Management, LLC of the Notes to the Condensed Consolidated Financial Statements. The Cooperation Agreement terminated
on the date following our 2024 annual meeting of stockholders. Under the terms of the Cooperation Agreement, our current Chair of the
Board, Mr. Gray, and four of our other current directors, Mr. Darling, Mr. Pate, Mr. Peterson and Ms. Serow, were appointed or nominated
to serve on our Board.
In the past, Coliseum has made an unsolicited bid to acquire the remaining outstanding shares of our Common Stock and has taken other related actions, which resulted in Coliseum and the Company entering into a cooperation agreement (the “Cooperation Agreement”). Under the terms of the Cooperation Agreement, our current Chair of the Board, Mr. Gray, and some of our other current directors were appointed or nominated to serve on our Board. There can be no assurance that Coliseum will not make another unsolicited bid to acquire the remaining outstanding shares of our Common Stock or attempt to nominate additional or replacement members to the Board. Such future actions by Coliseum may require us to devote significant additional resources and time that would otherwise be directed at our business and operations or may demotivate current executives and discourage other executives from joining the Company. In addition, such actions could cause the price of our Common Stock to change based on investors’ perceptions of Coliseum’s actions and Coliseum’s influence over the Company and our Board.
We have engaged in numerous
related-party transactions with significant
stockholders, directors, and their affiliated entities. For example, under the Amended and
Restated Credit Agreement, as amended by the
2025 Amendment, the Second 2025 Amendment, and the Third Amendment, the Lenders, which include
Coliseum, have loaned to us an aggregate of $80.0$100.0 million and we have issued Warrants to Coliseum
and the other Lenders to purchase an
aggregate of 26.232.8 million shares of our common stock at $1.50 per share. Coliseum, our largest stockholder,
has appointed or nominated
a total of five directors to serve on our Board, each of whom continues to serve on our Board, including, Adam
Gray, who continues to
serve as Chairman. Any future transactions with the Lenders or any other related parties may give rise to conflicts
of interest or otherwise
adversely affect our business.
Our preliminaryexploration exploration
of potential
strategic alternatives may not be successful, which may adversely affect our ability to compete with larger, including combined,
competitors.
We regularly engage in dialogue
with market participants regarding potential business combinations, partnerships and other strategic alternatives. Based on certain recent
preliminary inquiries, the Board has formed a special committee of independent directors and we have engaged a financial advisor to support
them in evaluating any indications of interest and exploring other potential strategic alternatives. There can be no assurance that any
of such preliminary exploratory activities will result in our engaging in a strategic alternative transaction, or even if we do so, that
any such strategic alternative transaction will result in favorable terms and conditions for us or our shareholders. If we are unsuccessful
in engaging in a favorable strategic alternative, then our ability to grow our business and compete with larger, including combined, competitors
may be adversely affected. As a result, we may face liquidity challenges in the long-term and our ability to achieve consistent profitability
may be adversely affected.
Our
success may depend on our ability to timely anticipate and respond to changing consumer trends. Those changes and resulting changes in
our product mix and distribution strategy could adversely affect our business and results of operations. For example, as retail stores
reopened following the COVID-19 pandemic, consumers shifted away from online retail purchases towards brick-and-mortar shopping. Our gross
profit margins for
sales through wholesale customers are lower than those in our DTC channel, so that shift adversely affected our gross
profit margins.channel. If we fail to identify and respond to emerging trends, consumer
acceptance of the products we manufacture and sell and
our image with current or potential customers may be harmed, which could reduce
our net sales. If we misjudge market trends, we may significantly
overstock inventory and be forced to take significant inventory markdowns,
which would have a negative impact on our gross profit and
cash flow. Conversely, shortages of inventory or increases in time for fulfillment
of our products that prove popular could also reduce
our sales.
The sleep products industry
is highly competitive and fragmented, with competition from manufacturers (including those sourcing from low-cost countries), traditional
retailers, and online direct-to-consumer brands. Competition centers on price, quality, brand recognition, availability, and performance
across various distribution channels. This competitive environment exposes us to risks of losing market share, significant customers,
margins, and new customer acquisition. We have introduced new products in the luxury mattress market but have limited experience in this
sector. If we fail to compete effectively with other manufacturers and retailers of our products, our sales,
profitability, cash flow,
and financial condition may be materially adversely affected.
Many of our significant competitors,
including established manufacturers, retailers, and new entrants, offer products directly competing with ours. This increasing competition
from both domestic and international sources, including competitors that source from low-cost locations such as China and Vietnam,locations, could
adversely affect our business,
financial condition and results of operations. Competitors are expanding their distribution channels, with
many offering direct-to-consumer
sales online. Major retailers like Mattress Firm, Amazon, and Walmart also sell competing products. Additionally,
foreign retailers may
vertically integrate by acquiring U.S. mattress manufacturers or other retailers. Many of our competitors
have greater financial
resources, technical expertise, larger customer bases, established industry relationships, and more mature distribution
channels. They
may aggressively pursue market share with new or existing products, and we cannot guarantee we will have the resources
or expertise to
compete successfully. Additionally, competitors with better e-commerce platforms could hurt our sales. We have limited
ability to predict
competitors’ actions, such as new product launches, pricing strategies, or marketing campaigns, which could impact
our market share
and product margins. Competitors may also secure better terms from vendors, adopt more aggressive pricing, and invest
more in technology
and marketing. With many competitors offering a wide range of products, it may be difficult for us to differentiate
through value, style,
or functionality. Additionally, our products are often heavier, and some markets may not support affordable delivery,
limiting our reach. The
retail sleep product industry has low barriers to entry, allowing new or existing retailers to increase competition.
This could delay
or prevent us from gaining market share and negatively impact our growth and future results of operations.
The Sleep products industry has experienced significant consolidation in recent years, including vertical integrations, with competitors acquiring brands to expand distribution networks, leverage economies of scale to gain market share and lower prices, gain greater bargaining power with suppliers, enhance brand recognition, advance research and development, and extend marketing and retail distribution channels. For example, the industry leader has recently made an offer to purchase one of our important suppliers. Consolidation among retailers may result in fewer sales channels or more restrictive terms for standalone brands. If we are unable to adapt to these industry shifts, our growth, results of operations, and market share could be adversely impacted.
We rely on external suppliers for key raw materials like polyurethane foam, oil, spring units, and our Hyper-Elastic Polymer® ingredients. Any supply issues, quality concerns, or price fluctuations could raise costs and hinder our ability to meet customer demand. Oil price increases from conflicts in the Middle East or elsewhere could increase the cost of freight or raw materials. These issues or concerns may be magnified to the extent we rely on a limited number of suppliers or a sole supplier. Competitive pressures may also limit our ability to pass on price increases, potentially leading to lost sales. Shortages of widely used components like foam and spring units, due to factors like increased demand, weather events, or supply chain issues, could impact our production and operations. If a supplier fails to deliver, we will need to find replacements, potentially on unfavorable terms. Any disruption in component supply could significantly interrupt production and raise costs.
Even with timely access to
raw materials, supply chain constraints, inflation, increased duties and tariffs, and other factors will increase shipping, labor, and
production costs. Rising costs for materials, transportation, and labor could impact our production efficiency, reduce gross margins,
and negatively affect our results of operations. Shipping costs and delays have in the past risen and may again in the future rise
due to regional conflicts, port closures, congestion, and shortages of containers and ships. Future disruptions, such as pandemics, geopolitical
conflicts, conflicts,
and increased duties and tariffs, could worsen delays and increase material costs. These issues may impact our ability to maintain
inventory, inventory,
meet demand, and affect our operations. Any significant supply chain interruptions or inability to source materials at acceptable
prices prices
could harm our business.
We collect and store personal
information from customers and suppliers, including customer payment details. We may share this information with third parties. Cyberattacks
targeting sensitive data are a known threat, and hackers may attempt to breach our systems or those of third parties. Employees, contractors,
or business partners could also intentionally or unintentionally compromise security. For example, we previously experienced an unauthorized
intrusion involving a former contractor’s credentials, though no personal information was accessed. Future breaches could occur
if there are weaknesses
in our internal controls over financial reporting related to information technology systems. We and third-party
partners have experienced
and, in the future, may experience various cyber-attacks, including phishing, malware, and ransomware attacks.
In 2022, we experienced a spear-phishing attack that led to a $140,000 loss due to unauthorized changes to a vendor’s bank account. We
expect continued exposure
to similar threats. Additionally, increasing use of artificial intelligence by us and our third-party partners
may increase these risks.
A breach releasing sensitive data could harm our reputation, result in financial losses, and increase our security
costs. Successful ransomware
attacks could disrupt our operations, and while our insurance may cover some losses, it may not be sufficient
for all liabilities. We
are subject to evolving data privacy and breach laws, both at the state level (e.g., the California Consumer Privacy
Act), the federal
level, and internationally as we expand. These laws’ rapid changes and potential inconsistencies increase compliance
costs and non-compliance
risks. While we aim to comply, failure to do so could result in fines, administrative actions, and reputational
damage.
Changes in U.S. trade policy including the impact of tariffs are having and may continue to have a material adverse effect on our business and results of operations.
Our business and results of operations are being and may continue to be adversely affected by uncertainty and changes in U.S. trade policies, including tariffs, trade agreements or other trade restrictions which may be imposed by the U.S. or other governments with little or no advance notice. For example, the recent U.S. Supreme Court ruling invalidating certain IEEPA tariffs resulted in the imposition of new replacement tariffs and created uncertainty with respect to recovering amounts paid for the invalidated tariffs. In the recent past, U.S. trade policy has resulted in retaliatory measures on U.S. goods and may result in further retaliatory measures. Further changes to trade policy may result in additional retaliatory measures. If we are unable to navigate further these unpredictable changes in U.S. or international trade policy, it could have a material adverse impact on our business and results of operations.
Some of our products require materials that may be subject to these recent tariffs, especially our products requiring textiles. In addition, some U.S manufacturers have asked the U.S. government to extend increased steel tariff protections to mattress springs. Any imposition of or increase in tariffs on imports of these products or components, as well as corresponding price increases for such materials available domestically, could increase our costs. To the extent that we are unsuccessful in finding alternative suppliers that are subject to smaller or no tariffs, negotiating sharing these costs with our suppliers, or failing to pass cost increases on to our customers, such cost increases could adversely affect our business and results of operations. Higher costs could also inhibit our ability to develop new products and innovations.
Tariffs or other trade restrictions may lead to continuing uncertainty and volatility in U.S. and global financial and economic conditions and commodity markets, declining consumer confidence, significant inflation, and diminished expectations for the economy, and ultimately may reduce demand for our products. Such conditions could have a material adverse impact on our business, results of operations and cash flows. Also, disruptions and volatility in the financial markets may lead to adverse changes in the availability, terms and cost of capital. Such adverse changes could increase our costs of capital and limit our access to financing sources, which could in turn reduce our cash flow and limit our ability to pursue growth opportunities.
Disruptions
to our manufacturing
operations, whether from the Restructuring Plan, a pandemic, natural disasters, lease issues, or equipment failures, could increase costs,
delay production and shipping, and negatively impact our business, operations, and financial condition. Workplace injuries, industrial
accidents, or violence could also lead to production suspensions and delays, affecting customer satisfaction, results of operations,
financial financial
condition including our cash flow. The Restructuringconsolidation Plan, which consolidatedof our manufacturing operations into one plant, may heighten
the risk
of disruption, particularly from regional economic downturns, hurricanes, pandemics, utility shortages, or other events affecting our
our Georgia plant, potentially harming our business.
We
rely on effective marketing messages and efficient advertising to drive consumer awareness and sales. We continually adjust our strategies,
including messaging, budget, and channels. However, we may struggle to adapt to changing consumer preferences, competition, and advertising
efficiency. We rely on internet-based advertising through media and e-commerce platforms. If these platforms become less effective,
lose users, or fail to target our audience, our advertising may lose effectiveness and adversely affect our business. Advertising costs
on social media platforms such as FacebookMeta have risenin the past and may in the future rise significantly, reducingwhich efficiency,could andreduce we expect costs to keep increasing.efficiency. We
rely on relationships with media partners, search engines, social media influencers, and e-commerce platforms to drive traffic and attract
customers. If we can’t maintain or develop these relationships on favorable terms, or if our reputation suffers, our ability to
grow could
be impacted. If we can’t manage these costs or generate expected sales, our business could be adversely affected.
Our
expansion into wholesale distribution and new sales channels, new products, market segments and geographic regions subjects us to additional
business, legal, financial,
and competitive risks.
MostIn
ofaddition our sales are throughto DTC channels, but we havecontinue expandedto expand into wholesale distribution. However, weWe cannot guarantee success with wholesale
partners. We may
struggle to generate additional sales through wholesale channels, and extending credit terms to wholesale partners could
expose us to
the risk of unpaid or late invoices. Providing fixtures to wholesale partners could also pose challenges in recovery or reuse. Wholesale
Wholesale customers may not purchase at expected volumes, and gross profit from wholesale sales are lower than DTC. If these issues arise, they
they could harm our reputation, limit growth, and negatively impact our results of operations.
WeOperating
may struggle to open additional Purple showrooms beyond those already established. Operating showrooms involves risks such as inventory
shrinkage, increased expenses, lease obligations, distribution challenges, and employee management.
If we fail to operate these stores
profitably or if we close unprofitable stores, it could harm our reputation, limit growth, and negatively
impact our business. Expanding
into new product offerings through e-commerce, wholesale, and Purple showrooms presents challenges, including
potential service disruptions,
quality issues, and customer claims. Expanding sales channels may also require new products to avoid conflicts
between channels. New products
may introduce warranty and return risks. Expanding into new markets or regions could expose us to additional
regulations, leading to increased
compliance and distribution costs.
We
rely on commercial agreements and strategic relationships with suppliers, service providers, and wholesale partners. Disruptions in these
relationships or strategic decisions by partners could negatively affect our business. For example, (i) one of our competitors is purchasing
one of our wholesale partners, which could disrupt our relationship or prevent us from continuing to sell our products in favorable placements
alongside the competitor’s products or at all in the wholesale partner’s stores, and (ii) one of our competitors owns a manufacturing
company with which we have a manufacturing relationship, and that competitor could disrupt that relationship to harm our manufacturing
efforts. We may also struggle to maintain or develop these relationships and may not be able to secure new ones on favorable terms.
We
rely on commercial agreements and strategic relationships with suppliers, service providers, and wholesale partners. Disruptions in these
relationships or strategic decisions by partners could negatively affect our business. For example, (i) the industry leader has acquired
one of our wholesale partners, which could disrupt our relationship or prevent us from continuing to sell our products in favorable placements
alongside the competitor’s products or at all in the wholesale partner’s stores, (ii) the industry leader owns a manufacturing
company with which we have a manufacturing relationship, and that competitor could disrupt that relationship to harm our manufacturing
efforts, (iii) the industry leader is attempting to purchase one of our key suppliers, and (iv) the industry leader is attempting to get
the U.S. Government to place import restrictions on an important international supplier. We may also struggle to maintain or develop these
relationships and may not be able to secure new ones on favorable terms, We
sell products through wholesale partnerships and may seek to expand these relationships. However, these wholesale partnerships may
not not
be profitable and could incur additional costs compared to our DTC operations. In addition, an expansion of these relationships
may concentrate our business with one customer resulting in greater reliance on that customer, which could adversely affect our
ability to grow our business and compete in our industry. Wholesale relationships may be terminated or modified,
or wholesale
partners may reduce orders or fail to meet their obligations, resulting in lost sales and adversely affecting our financial
performance, results of operations and financial condition. Disputes with partners or the termination or amendment of agreements
could could
lead to expenses, delayed payments, liabilities, and distractions from our strategic objectives. If we cannot renew or replace
agreements agreements
on favorable terms, it could harm our business. Wholesale partners may also compete against us in key channels,
harming our business.
Maintaining these relationships may require significant resources and could limit our sales channels,
adversely affecting other areas
of our business.
We use some third-party manufacturers to assemble certain of our products using Company-made Hyper-Elastic Polymer material. We depend on our third-party manufacturers to maintain high levels of productivity and satisfactory delivery schedules. These third-party manufacturers may experience difficulties assembling our products, particularly in the early stages of their engagement as they develop expertise in assembling our products to our standards. For example, we previously experienced temporary issues with certain third-party manufacturers assembling our mattresses and the occurrence of such issues in the future would materially harm our business. The ability of our suppliers to effectively satisfy our production requirements could also be impacted by their financial difficulty or damage to their operations caused by fire, pandemic, terrorist attack, natural disaster, or other events. The failure of any supplier to meet our expectations could result in supply shortages or delays for certain products and components and harm our business.
We offer consumer financing
through third-party finance companies, with a significant portion of our sales financed in 2024.2025. Macroeconomic factors and changes in
credit lending criteria may reduce available credit, and we may face higher costs to maintain lending approvals. Additionally, federal
regulations are placing moreplace restrictions on consumer credit programs, including promotional credit offers. Some of our agreements with
third-party finance companies, which offer financing to our customers, may be terminated by them with 30 days’ notice. They control financing
offers and credit
standards and may provide better terms to our competitors or in channels outside our focus. Reduced credit availability
from economic
changes, regulatory shifts, terminated agreements, or competitors offering better terms could negatively impact our results
of operations
and financial condition.
We
have in the past accumulated and may again in the future accumulate excess raw material inventory, which is vulnerable to shrinkage, theft,
obsolescence, or otherwise becoming unsellable, and excess finished product inventory. Excess inventory uses valuable warehouse space.
If our efforts to manage inventory are unsuccessful, excess stock and related inefficiencies could negatively impact our results of operations.
On the other hand, failing to maintain adequate inventory levels could lead to supply shortages, harming our ability to meet consumer
demand and negatively affecting operations. Lead times for products and components, especially those sourced internationally, can vary.
Risks from legal, economic, political, or health issues, as well as disruptions in global trade, including due to tariffs or trade wars,
could impact production and result in inadequate inventory levels. Sourcing challenges, particularly from China,challenges due to trade tensions,
tariffs or other geopolitical
factors, will also increase costs and disrupt supply. Any shortages or delays in meeting demand could harm
customer satisfaction, results
of operations and financial condition.
We rely on key suppliers, some of which are our only source or one of few sources for certain products, materials, or services. While alternative suppliers may be available, disruptions or cost increases in the supply of materials could negatively affect our results of operations and financial condition. Additionally, changes in a supplier’s financial condition could delay their product delivery to us. Shipping delays from port closures, congestion, and shortages of containers or ships could disrupt manufacturing, supply of materials, and inventory management. These delays may hinder our ability to meet product demand and deliver on time, negatively impacting our business and results of operations.
The U.S. Consumer Product
Safety Commission (CPSC) and other jurisdictions have fire retardancy standards for the mattress industry, withand some statesjurisdictions and Congressmay
consideringconsider stricter regulations. These standards require fire retardant materials, quality assurance programs, random product testing, and
and documentation retention, which can be costly. If testing or inspections show our products don’t meet flammability standards, we
we could face production halts, recalls, fines, or penalties, negatively impacting our operations and financial condition. New legislation
on fire retardancy, bed bug prevention, or mattress recycling could lead to recalls or higher operating costs. Non-compliance may result
in penalties, business restrictions, or negative publicity. Conflicting regulations could raise costs, change manufacturing processes,
and harm product performance, negatively affecting our business.
We may be involved in legal
proceedings arising in the ordinary course of business, including commercial, product liability, employment andemployment, intellectual property claims,
claims.and claims brought by shareholders. Litigation is unpredictable, and it is possible that the outcome of future claims asserted, or adverse
publicity resulting from
litigation, could adversely affect our business, reputation, results of operations or financial condition.
Before the Business Combination,
we entered into an Amended and Restated Confidential Assignment and License Back Agreement with EdiZONE, controlled by our founders, pursuant
to which EdiZONE transferred intellectual property to us and licensed back certain intellectual property to meet pre-existing third-party
obligations. EdiZONE agreed not to modify, extend, or enter new third-party licenses, with all rights reverting to us as these licenses
expire. One of EdiZONE’s prior licenses grants exclusivity to a third party of an earlier technology that could prevent us from
selling a mattress made from that earlier technology in the European Union.Union or in the medical industry. This risk could be mitigated by
redesigning our Hyper-Elastic
Polymer material using existing or new technologies. However, there is no guarantee that any of our future
sales in the European Union
or in the medical industry won’t be challenged by EdiZONE’s licensee, and any such redesigned
mattresses may not succeed. If challenged, we are required
to indemnify EdiZONE. We have the right to enforce our intellectual property
against licensees who violate their agreements or infringe
on our intellectual property. We must indemnify EdiZONE and cover enforcement
costs. However, there is no guarantee that such enforcement
efforts would succeed, which could negatively impact our business.
Our Commoncommon Stockstock is currently
listed on NASDAQ, which has listing criteria. We cannot assure that our Commoncommon Stockstock will continue to be listed on NASDAQ in the future.
To continue listing our Commoncommon Stockstock on NASDAQ, we must maintain certain governance, financial, distribution and stock price levels.
Generally, Generally,
we must maintain a minimum amount in stockholders’ equity, a minimum number of holders of our Commoncommon Stock,stock, and a $1.00
minimum minimum
per share bid price for our Commoncommon Stock.stock. If we fail to maintain a $1.00 minimum per share bid price for a period of 30 consecutive
business business
days, we have 180 calendar days to maintain our Commoncommon Stockstock at a $1.00 minimum per share bid price for 10 consecutive trading
days. If
we do not regain compliance within 180 calendar days, NASDAQ may grant a second compliance period of 180 calendar days or it
may determine
to delist our Commoncommon Stock,stock, at which point we would have an opportunity to appeal the delisting determination to a hearings
panel. On
November 11,5, 2024,2025, we received written notice from NASDAQ that we were not in compliance with Nasdaq minimum share price rule,
since the
closing price of our Common Stock had been below $1.00 per share for 30 consecutive business days. However,We have 180 calendar days,
or until May 4, 2026, to regain compliance with the Nasdaq minimum share price rule. To regain compliance, the bid price of our Common
Stock must close at $1.00 or more for a minimum of ten consecutive business days. While we regainedintend suchto complianceactively monitor the bid price of
onour FebruaryCommon 3,Stock 2025.and Itwill isconsider possibleavailable options to regain compliance, there can be no guarantee that we maywill againbe failable to regain compliance
or otherwise comply with suchNASDAQ’s minimumother bidcontinued pricelisting requirement in the future if our stock
price again falls below $1.00 for an extended period. Currently, our stock price has been below $1.00 since February 19, 2025.requirements.
As reported by Coliseum in
its Schedule 13D/A filed on JanuaryMay 23,6, 2024,2025, Coliseum beneficially owns 58.561.1 million shares of Common Stock (which includes 46.9 million shares
shares of Common Stock currently owned and 11.614.2 million shares of Common Stock that could be acquired upon exercise of its Warrantswarrants).
The existence
of such a large stockholder may limit the potential for third party offers to acquire the Company.
In
connection with the issuance of Warrantswarrants pursuant to the Amended and Restated Credit Agreement and the 2025 Amendment, the Companywe entered
into a Second Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”)
with CCP, Blackwell,
Coliseum Capital Co-Invest III, L.P. (“C-3”), Harvest Master, Harvest Partners, and HSCP (the
“Holders”), providing
for the registration of the Warrants,warrants, the shares of Common Stock issuable upon the exercise of the Warrants,
warrants, and the Class A Common Stock
held by the Holders as of such date (the “Registrable Securities”). The market
price of our Common Stock could decline as
a result of sales by a few large stockholders, such as Coliseum or the Holders, or the
perception that these sales could occur, including
as a result of the registration statement. These sales might also make it more
difficult for us to sell equity securities at a time and
price that we deem appropriate.
We have previously sold and
may in the future sell additional shares of our Commoncommon Stockstock or convertible securities at prices that are lower than the prices paid by
existing stockholders, and investors purchasing shares or other securities could have rights superior to existing stockholders, which
could result in substantial dilution of existing stockholders. For example, in February 2023 we issued 13.4 million shares of Common Stock
pursuant to a public offering, on January 23, 2024, we issued to the Lenders under the Amended
and Restated Credit Agreement the 2024
Warrantswarrants to purchase 20.0 million shares of our Commoncommon Stockstock at a price of $1.50 per share (the “2024
Warrants”), subject to adjustments, and on March 12, 2025, we issued to the 2025 Lenders under the 2025 Amendment the 2025 Warrants
to purchase 6.2 million shares of our common stock at a price of $1.50 per share, subject to adjustments,adjustments. andIn addition, on MarchMay 12,2, 2025,
we issued to the 2025 Lenders under the Second 2025 Amendment additional warrants (the “2025 Additional Warrants”) to purchase 6.2
6.6 million shares of our Commoncommon Stockstock at a price of $1.50 per share, subject to adjustments and on May 2, 2025, we issued to Somnigroup
International, Inc. as partial consideration for their entering into various agreements with Somnigroup International, Inc. entities,
warrants to purchase 8.0 million shares of our common stock at a price of $1.50 per share, subject to adjustments. The exercise of the Warrants warrants
will dilute the value of Class A common stock and stockholder voting power. In
addition, the Warrantswarrants include full-ratchet anti-dilution
protections, subject to certain conditions, which could result in the Warrants
warrants becoming exercisable for a significantly greater number
of shares if we engage in a dilutive financing.
We are required to maintain
internal controls over financial reporting and disclosure, as mandated by the Sarbanes-Oxley Act and SEC rules. However, even with these
controls, management cannot guarantee that they will prevent all errors or fraud. All control systems have inherent limitations, such
as human error, circumvention, or collusion, and cannot provide absolute assurance of detection or prevention. Controls may also become
inadequate over time due to changes, new fraudulent schemes, or deteriorating compliance, increasing the risk of undetected misstatements.
The accuracy of our financial reporting relies on effective internal controls, which can only provide reasonable assurance and may not
detect all misstatements. We have in the past identified material weaknesses in our controls. Any failure in internal controls or disclosure
procedures could undermine the accuracy and timeliness of our
disclosures, potentially eroding investor confidence, requiring significant
resources to fix, and exposing us to legal or regulatory actions.
For example, we identified a material weakness in our warranty reserve accounting during the preparation of our September 30, 2023, financial
statements. However, as of June 30, 2024, we concluded that the material weakness has been remediated and that our internal controls over
financial reporting are effective.
Under Section 382 and related
provisions of the Internal Revenue Code
of 1986, as amended (the “Code”), if a corporation undergoes an “ownership change”,
the corporation’s ability
to use its pre-change net operating loss carryforwards (“NOLs”) and other pre-change tax attributes
to offset its post-change
income may be limited. Generally, an ownership change is defined as a change in its equity ownership by certain
stockholders over a three-year
period of greater than 50 percentage points (by value). If finalized, Treasury Regulations currently proposed
under Section 382 of the
Code may further limit our ability to utilize our pre-change NOLs or other tax attributes if we undergo a future
ownership change. Thus,
our ability to utilize carryforwards of our net operating losses, including net operating losses acquired from
the Intellibed acquisition,
and other tax attributes to reduce future tax liabilities may be substantially restricted. As of December 31,In 2024, we completed
a study
to assess whether an ownership change has occurred, as defined by IRC Section 382, or whether there have been ownership changes
since since
the Company’s formation. The results of this study indicate that we experienced one ownership change on December 31, 2021.
We may also
experience ownership changes in the future as a result of subsequent shifts in our stock ownership. As a result, if we generate
taxable taxable
income, our ability to use our pre-change NOL and tax credits carryforwards to reduce U.S. federal and state taxable income may
be subject
to further limitations, which could result in increased future tax liabilities to us. Moreover, our federal NOLs from years
prior to 2018
can be carried forward for a maximum of 20 years from the year in which the NOL was incurred, and our state NOLs are subject
to carryforward
limitations that vary from state to state; as a result, all or a portion of those carryforwards could expire before being
available to
reduce future income tax liabilities.
On June 27, 2024, our Board
approved the NOL Rights Plan to protect stockholder value by attempting to safeguard our ability to use Current NOLs of approximately
$310.7 million to reduce potential future federal income tax obligations from becoming substantially limited by future ownership of our
Common Stock. At the Special Meeting, stockholders ratified the NOL Rights Plan. Under the NOL Rights Plan, the Board authorized and declared
a dividend of one Right for each outstanding share of Common Stock to stockholders of record at the close of business on July 26, 2024.
Upon a stockholder acquiring greater than a 4.9% ownership percentage threshold (or, if a stockholder has beneficial ownership of in excess
of 4.9%, then the ownership percentage that is one-half of one percentage point greater than their current beneficial ownership percentage),
the Rights will become exercisable to significantly dilute any stockholder who violates the ownership limitations of the NOL Rights Plan.
In connection with the NOL Rights Plan, the Board adopted, and our stockholders approved at the Special Meeting, the NOL Protective Charter
Amendment that adds an additional layer of protection to our Current NOLs until June 30, 2025 by voiding any transfer of Common Stock
that results in a stockholder acquiring beyond a 4.9% ownership percentage threshold (or, if a stockholder has current beneficial ownership
of in excess of 4.9%, then the ownership percentage that is one-half of one percentage point greater than their current beneficial ownership
percentage).
There is continued risk
of ownership change under Code Section 382.
Although the NOL Protective
Charter Amendment and NOL Rights Plan intend to reduce the likelihood of an ownership change under Code Section 382, we cannot ensure
that the NOL Protective Charter Amendment and the NOL Rights Plan will be effective. The amount by which a future ownership interest under
Code Section 382 may change could, for example, be affected by purchases of our Common Stock by stockholders who are 5% stockholders (as
defined under Code Section 382) or by purchases of stock or other interests in corporations, partnerships or other legal entities that
own 4.9% or more of our Common Stock, over which we have no control. Further, while the NOL Protective Charter Amendment and the NOL Rights
Plan allow for the exercise of currently outstanding conversion rights, exchange rights, warrants or options or otherwise, such exercises
may result in an ownership change under Code Section 382. It may also be in our best interests, considering all relevant facts and circumstances
at the time, to permit the acquisition of our Common Stock in excess of the specified limitations or to issue new or redeem existing equity
in the future, all of which may increase the likelihood of an ownership change under Code Section 382.
The Current NOL protections
under the NOL Protective Charter Amendment and NOL Rights Plan will expire by their terms on June 30, 2025.
The NOL Protective Charter
Amendment and the NOL Rights Plan may potentially adversely affect the market for, and negatively impact the value of, our Common Stock.
The NOL Protective Charter
Amendment and the NOL Rights Plan intend to prohibit or deter a stockholder’s ability to acquire, directly, indirectly or constructively,
additional shares of our Common Stock in excess of specific limitations. A stockholder’s ability to dispose of our Common Stock
may be limited by reducing potential acquirers for such shares. A stockholder’s ownership of our Common Stock may become subject
to the restrictions of the NOL Protective Charter Amendment, or may trigger applicable thresholds under the NOL Rights Plan, upon actions
taken by Persons (as such term is defined in the NOL Protective Charter Amendment or the NOL Rights Plan, as applicable) related to, or
affiliated with, such stockholder.
Management's Discussion & Analysis (MD&A)
New heading “Impact of United States Tariff Policy”
Removed heading “Loss on Impairment of Goodwill”
Largest changes
“We have taken a number of actions to increase cash flow and support our operations and strategies. In August 2024, we implemented the Restructuring Plan (as defined below) to consolidate manufacturing operations resulting in cost savings. We have realized and plan to continue to realize direct material cost savings by concentrating efforts on driving gross margin improvement through various methods such as selective pricing actions, continued mix shift towards the Restore and Rejuvenate collections, and by driving cost savings through supply chain initiatives and manufacturing efficiency. …”see in full comparison
“On March 24, 2026, the Loan Parties entered into the Third Amendment with the Lenders, which revised the maturity date under the Amended A&R Credit Agreement from December 31, 2026, to April 30, 2027 and waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. In connection with the Third Amendment, the Loan Parties agreed to pay to the Lenders an amendment fee in the aggregate amount of $1.6 million, equal to 1.25% pro rata based on each Lender’s outstanding principal amount (the “Amendment Fee”). …”see in full comparison
“Net cash used in operating activities was $17.9 million in 2024 compared to $54.7 million in 2023. Operating activities in 2024 reflected a net loss of $98.1 million offset in part by non-cash adjustments of $75.9 million and working capital changes of $4.3 million. …”see in full comparison
“In August 2024, we initiated a Restructuring Plan to permanently close our two Utah manufacturing facilities and consolidate mattress production in our Georgia plant. The Restructuring Plan also provided for a headcount reduction at our Utah headquarters to drive additional operating efficiencies. …”see in full comparison
“We continue to actively manage the impact of recent United States tariff policies. Importantly, all of our mattresses are manufactured in the United States, and about 15% of our cost of goods is tied to products sourced from overseas. This limited exposure is primarily concentrated in the textile side of the business, which includes sheets and mattress covers, but also includes the import of bases and foundations. Tariffs impacted us by approximately $9.1 million in 2025 due to our mitigation efforts which have reduced the overall impact to our initial expectations. …”see in full comparison
In August 2024, we initiated the Restructuring Plan to strategically realign our operational focus to achieve efficiencies in our operationssee in full comparisonthat are expectedto improve profitability and provide for reinvesting in technology and marketing initiatives. The Restructuring Planincludesincluded the permanent closure of both Utah manufacturing facilities to consolidate mattress production in our Georgia plant, and a headcount reduction at our Utah headquarters to drive additional operating efficiencies. Closure of the two Utah manufacturing facilitiesis projected to bewas completed in the second quarter of 2025 while consolidation into the Georgia facility was finalized in December 2024. The reduction in workforce at our Utah headquarters was completed in August 2024. The Restructuring Plan is now complete. During2024,2025, we recognized$36.4$12.4 million in costs relating to the Restructuring Plan,Plan.,of whichincluded $4.3 million of employee-related costs, $11.3 million of accelerated depreciation, $9.3$9.5 million related towrite-downsthe write-off ofinventoryequipment that was determined to have no future use andlong-lived$2.9assets to be disposed of or equipmentmillion inprogress that will not be put in service, $11.0 million of impairment charges associated with entering into a subleaseemployee-relatedfor one of the Utah manufacturing facilities to be closed and impairment of an intangible asset, and $0.5 million of other related costs. We expect to record additional restructuringand otherrelatedcashcharges in the amount of $4.6 million through the second quarter of 2025. These charges include certain estimates that are provisional and include management judgments and assumptions that could change materially as we complete the execution of our plans. Actual results may differ from these estimates, and the completion of our plan could result in additional restructuring, impairment or other related charges not reflected.charges.
Full comparison: every changed paragraph (93)
Our mission is to deliver the greatest sleep ever invented.
Our
mission is to help people feel and live better through innovative comfort solutions.
We are an omni-channel company that began as a digitally-native
vertical vertical
brand founded on comfort product innovation with premium offerings.offerings, and have since expanded into brick & mortar stores as
a true omni-channel brand. We design and manufactureoffer a variety of innovative, branded and premium
comfort products, including mattresses, pillows, cushions,
bases, frames, sheets, duvets, duvet coverssheets and other products.more. Our products are the
result of over 30 yearsdecades of innovation and investment in proprietary and patented comfort technologies
and the development of our own manufacturing
processes. Our proprietary Hyper-Elastic Polymer gel technology underpins many of our comfort
products and provides a range of benefits
that differentiate our offeringsproducts from otherour competitors’competitors. products.Specially Weengineered marketto relieve pressure,
maintain an ideal body temperature, and sellprovide instantly adaptive support, Purple’s patented technology has been tested rigorously
within medical and consumer applications for over 30 years. Originally designed for use in hospital beds and wheelchairs, we adapted this
unique pressure-relieving material for our productsmattresses, via our DTC channel, which includes
Purple.com (our direct-to-consumer e-commerce), Purple showrooms, our customer contact centerpillows and onlineother marketplaces,cushion and our wholesale
channel through retail brick-and-mortar and online wholesale partners.products.
We market and sell our products via our direct-to-consumer channel, which includes Purple.com (our direct-to-consumer e-commerce), Purple showrooms, our customer contact center and online marketplaces (collectively “DTC”), and our wholesale channel through retail brick-and-mortar and online wholesale partners.
Our
business consists of Purple
Inc. and its consolidated subsidiary, Purple LLC. Purple Inc. was incorporated in Delaware on May 19, 2015
as a special purpose acquisition company under the name of GPAC. On February 2, 2018, we consummated a transaction structured similar
to a reverse recapitalization (the “Business Combination”) pursuant to which Purple Inc. acquired an equity interest in Purple
LLC as holder of all Class A units and became its sole managing member. As the sole managing member of Purple LLC, Purple Inc., through
its officers and directors,
is responsible for all operational and administrative decision making and control of the day-to-day business
affairs of Purple LLC without
the approval of any other member. At December 31, 2024,2025, Purple Inc. had a 99.8%99.85% economic ownership interest in Purple
LLC while other Class
B unit holders had the remaining 0.2%.0.15%.
On
August 31, 2022, we acquired all the issued and outstanding stock of Intellibed to consolidate ownership of our licensed intellectual
property while enhancing our innovation and manufacturing capabilities and financial profile. For further discussion see Note 4 —
Acquisition.
During 2024,2025, we continued
to build on our Path to Premium Sleep strategy. As a result, we exited 2025 with a lower cost structure and improved margins, which we
believe position us to scale as demand improves. We have been realizing efficiencies with our media investments
by targeting specific
segments most likely to purchase Purple and by focusing more effort on those consumers currently in the market for
a sleep product. We
are concentrating efforts on driving gross margin improvement through various methods such as selective pricing actions,
continued mix
shift towards our Restore and Rejuvenate collections, and by driving cost savings through supply chain initiatives and manufacturing efficiency.
efficiency. We have also delivered direct material cost savings from our supplier diversification efforts, improved scrap and yield results
from continuous
improvements, and our outbound freight costs reflect cost improvements along with improved delivery reliability. Moreover,While our revenues were
down overall from 2024, we believeare consolidationencouraged by our performance in the second half of 2025 as our fourth quarter 2025 revenue increased 9.1%
compared to last year, reflecting the continued execution of our manufacturingstrategic footprintpriorities. pursuantWholesale torevenue ourgrew Restructuring39.8% Plan is an important step to advance our grid innovation
and build momentum to achieve positive operating cash flow and market share growth overin the long- term. The fourth quarter
compared 2024to waslast significant
foryear uswith asour weexpanded achievedMattress profitabilityFirm placements and positivean cashexpansion flow.with Thisour wasCostco program, showroom revenue increased
4.5% reflecting the direct resultstrength of our disciplinedupdated execution,selling operationalmodel improvements
and costpremium savingpositioning initiativesand throughoute-commerce was down 15.3%, reflecting a continuation
of trends from earlier in the year. OtherGross keymargin highlights duringfor the fourth quarter was 41.9% as we have realized the benefits of 2024the includedcontinued significant improvementsimprovement
in Purplelowering showroommaterial profitabilitycosts from ongoing sourcing initiatives, plant efficiencies, restructuring benefits and theactions successfulto launch ofreduce our productcost
of warranty returns. Operating expenses continue to decline with 2.9% reduction in Costcothe retailfourth locations.quarter 2025 compared to last year as we
have improved efficiency, implemented numerous cost reduction efforts and closely managed our expenses with disciplined cost controls.
On May 2, 2025, we entered into the Second Amendment to Master Retailer Agreement with Mattress Firm (the “MRA Amendment”), a business unit of SGI, which provides that SGI, through its Mattress Firm stores, will expand its inventory of our products across its national store network from approximately 5,000 mattress slots to a minimum of 12,000 mattress slots. This rollout is progressing well, with Purple products now being represented in Mattress Firm’s full store network. With the recent launch of Purple Royale, our exclusive Luxe product for Mattress Firm, we have expanded to all 12,000 committed slots. Also on May 2, 2025, we entered into an Amended and Restated Master Vendor Supply and Services Agreement with Tempur Sherwood, LLC, a subsidiary of Tempur Sealy (the “Sherwood Agreement,” and together with the MRA Amendment, the “SGI Agreements”). The Sherwood Agreement provides that Tempur Sherwood, LLC has the exclusive right to assemble certain product lines that we sell to Mattress Firm.
The new Rejuvenate 2.0 collection launched in the second quarter 2025 and is available across all of our showroom locations. Momentum remains strong in our showrooms as Rejuvenate 2.0 mattress sales represented over half of showroom mattress revenue in the fourth quarter 2025. In conjunction with the launch of Rejuvenate 2.0, our slot placement expanded with our other wholesale partners.
We are also seeing strong performance with Costco, where our programs provide an important opportunity to introduce Purple to new customers at scale. Our Costco partnership expanded meaningfully at the beginning of the fourth quarter 2025 to 450 clubs. Early in the period, it performed exceptionally well, driven by the introduction of unrolled beds on the floor, which allowed Costco members to see and feel our differentiated product. This in-store presentation drove strong sales outperformance and ultimately led Costco to expand the program. We are also making progress in alternative channels, including Walmart and Sam’s Club, which are helping us to reach new customers, diversify demand, and drive incremental volume.
In 2025, we announced the
re-launching of our Rejuvenate line in the second quarter 2025 through our DTC channels, followed by a full wholesale channel roll-out
expected to be complete by the third quarter 2025. The new Rejuvenate 2.0 will have a newly innovated grid technology that when stacked
with our original Gelflex grid, creates a unique combination that continues to differentiate us in the market while driving superior comfort
and support for an even more premium sleep experience.
In August 2024, we initiated
the Restructuring Plan to strategically
realign our operational focus to achieve efficiencies in our operations that are expected to improve profitability
and provide for reinvesting
in technology and marketing initiatives. The Restructuring Plan includesincluded the permanent closure of both Utah
manufacturing facilities to
consolidate mattress production in our Georgia plant, and a headcount reduction at our Utah headquarters to
drive additional operating
efficiencies. Closure of the two Utah manufacturing facilities is projected to bewas completed in the second quarter of 2025
while consolidation
into the Georgia facility was finalized in December 2024. The reduction in workforce at our Utah headquarters was
completed in August
2024. The Restructuring Plan is now complete. During 2024,2025, we recognized $36.4$12.4 million in costs relating to the Restructuring
Plan, Plan.,of which included $4.3 million of employee-related
costs, $11.3 million of accelerated depreciation, $9.3$9.5 million related to write-downsthe write-off of inventoryequipment that was determined to have no future use and long-lived$2.9 assets to be disposed
of or equipmentmillion in progress that will not be put in service, $11.0 million of impairment charges associated with entering into a subleaseemployee-related
for one of the Utah manufacturing facilities to be closed and impairment of an intangible asset, and $0.5 million of other related costs.
We expect to record additional restructuring and other relatedcash charges in the amount of $4.6 million through the second quarter of 2025.
These charges include certain estimates that are provisional and include management judgments and assumptions that could change materially
as we complete the execution of our plans. Actual results may differ from these estimates, and the completion of our plan could result
in additional restructuring, impairment or other related charges not reflected.charges.
In addition, we planimplemented to implement
additional cost savings measures in 2025 and
2026 beyond those implemented pursuant to our 2024 Restructuring Plan.
On January 23, 2024, Purple
LLC, Purple Inc. and Intellibed (collectively, the “Loan Parties”) entered into the Amended and Restated Credit Agreement,
which amended and restated the then existing term
loan agreement (“Term Loan Agreement”), with CCP and other lenders (collectively,
the “Lenders”) and Delaware Trust Company, as administrative agent. The Lenders
agreed to assume our obligations under the
Term Loan Agreement and agreed to refinance our existing obligations. Pursuant to the Amended
and Restated Credit Agreement, we borrowed
$61.0 million from the Lenders (the “Related Party Loan”) that was used to repay
the $25.0 million of term loans outstanding,
the $5.0 million of revolving debt outstanding, loan fees, premiums and expenses incurred
in connection with this transaction and provided
net proceeds to us (after payments of outstanding debt, unpaid accrued interest, and
expenses) of approximately $27.0 million. Interest
on the new loan is payable each month andand, under the Third Amendment executed in March
2026 (see below), the principal outstanding matures and is due on DecemberApril 31,30, 2026.2027. To reduce cash obligations,
we have elected for interest
to be capitalized and added to the principal amount of the loan. The loan bears interest at a rate equal
to (i) the secured overnight
financing rate plus 0.10%, with a floor of 3.5% per annum, plus (ii) 8.25% per annum (or, because Purple
LLC has elected to pay interest
in kind to reduce its cash obligations, 10.25% per annum). Any prepayments of principal on or after August
7, 2024 but before August 7,
2025 are subject to a prepayment penalty of 1.25%, and any prepayments of principal on or after August 7,
2025 are subject to a prepayment
penalty of 2.50%. We may request an additional term loan from the Lenders in an aggregate amount not
to exceed $19.0 million on terms
requested by us to the extent agreed to by the Lenders at their discretion. The Amended and Restated
Credit Agreement also removed restrictions
and requirements typically associated with an asset-based loan. In connection with our execution
of the Amended and Restated Credit Agreement,
all obligations under the previously outstanding term loans and revolving credit facility
were paid in full and the respective related
agreements (collectively, the “2023 Credit Agreement”) were terminated.
On March 12, 2025, the Loan Parties, entered into the 2025 Amendment with CCP and Blackwell, which amends the Amended and Restated Credit Agreement. The 2025 Amendment, among other things, provides for an increase in the initial principal amount of the Related Party Loan by $19.0 million (the “First Incremental Loan”) from an initial Related Party Loan principal amount of $61.0 million to an initial aggregate principal amount of $80.0 million, and allows the Loan Parties to request one or more additional term loans from CCP, Blackwell and other lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended and Restated Credit Agreement). The First Incremental Loan will bear interest at the same rate as the Initial Loan, which may be paid in cash or in kind at our option.
The 2025 Amendment also provides that (i) the First Incremental Loan shall be senior in right of repayment to the Related Party Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the First Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (i) the Make-Whole Premium (as defined below) and (ii) 2.50% of the aggregate principal amount of the First Incremental Loan so prepaid, replaced or assigned. The “Make-Whole Premium” is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such First Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such First Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such First Incremental Loan on such prepayment date.
In addition, we also paid (i) an amendment fee equal to 2% of the outstanding principal and accrued and unpaid interest under the Related Party Loan held by the 2025 Lenders, paid in kind and (ii) a 2% work fee of the initial aggregate principal amount of the First Incremental Loan paid to the 2025 Lenders, deducted from the proceeds at closing. Total fees and expenses of $2.1 million were recorded as debt issuance costs in March 2025.
In connection with the 2025 Amendment, we issued to the 2025 Lenders, the 2025 Warrants to purchase 6.2 million shares of our Common Stock at a price of $1.50 per share, subject to certain adjustments (see Note 11 – Warrant Liabilities). The 2025 Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035.
On May 2, 2025, the Loan Parties entered into the Second 2025 Amendment with the 2025 Lenders (as defined in the Second 2025 Amendment), which amends the Amended A&R Credit Agreement. The Second 2025 Amendment, among other things, provides for a commitment increase pursuant to Section 2.18 of the Amended A&R Credit Agreement in the initial principal amount of the senior secured term loan facility by $20.0 million (the “Second Incremental Loan”) from an aggregate principal amount of up to $80.0 million (the “Existing Loan”) to an initial aggregate principal amount of up to $100.0 million and allows the Loan Parties to request one or more additional term loans from the Lenders in an initial aggregate principal amount not to exceed $20.0 million on terms to be agreed to by the parties and subject to the approval of the Required Lenders (as defined in the Amended A&R Credit Agreement). The Second Incremental Loan will bear interest at the same rate as the Existing Loan, which may be paid in cash or in kind at our option.
The Second 2025 Amendment also provides that (i) the Second Incremental Loan shall be senior in right of repayment to the initial $61.0 million loan under the Amended and Restated Credit Agreement and pari passu with the First Incremental Loan and (ii) in any voluntary or mandatory prepayment in part or in full of the Second Incremental Loan for any reason, the Company will be required to pay an amount equal to the greater of (a) the Make-Whole Premium (as defined below) and (b) 2.5% of the aggregate principal amount of the Second Incremental Loan so prepaid, replaced or assigned. The “Make-Whole Premium” is determined as follows: on the date of prepayment, the excess of (A) (x) 100% of the principal amount of such Second Incremental Loan, plus (y) the present value at such date of all remaining scheduled interest payments due on such Second Incremental Loan from the prepayment date through the maturity date, assuming that all such interest accrues at the Make-Whole Premium Rate (as defined in the Second 2025 Amendment), computed using a discount rate equal to the Treasury Rate as of such prepayment date plus 50 basis points, over (B) the principal amount of such Second Incremental Loan on such prepayment date.
In addition, we also paid (i) an amendment fee equal to 0.25% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in kind to the 2025 Lenders, (ii) a work fee equal to 0.1% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, (iii) a waiver fee, to induce the Required Lenders to waive certain preemptive and right of first refusal rights, equal to 0.15% of the outstanding principal and accrued and unpaid interest under the Existing Loan, paid in cash to the Required Lenders, and (iv) a commitment fee equal to $0.2 million, paid in cash to the Required Lenders.
In connection with the Second 2025 Amendment, we issued to the 2025 Lenders, warrants (the “2025 Additional Warrants”) to purchase 6.6 million shares of our Common Stock at a price of $1.50 per share, subject to certain adjustments. These 2025 Additional Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035.
On March 24, 2026, the Loan Parties entered into the Third Amendment with the Lenders, which revised the maturity date under the Amended A&R Credit Agreement from December 31, 2026, to April 30, 2027 and waived certain requirements and events of default relating to the going concern qualification in our December 31, 2025 financial statements. In connection with the Third Amendment, the Loan Parties agreed to pay to the Lenders an amendment fee in the aggregate amount of $1.6 million, equal to 1.25% pro rata based on each Lender’s outstanding principal amount (the “Amendment Fee”). Of the Amendment Fee, approximately $1.3 million is payable-in-kind by adding such amount to such Coliseum Lenders’ outstanding principal amount. The remaining $0.3 million of the Amendment Fee was paid in cash. In connection with the Third Amendment, the Loan Parties also agreed to reimburse the Coliseum Lenders for certain expenses in the amount of $0.3 million.
The Company has elected to have interest paid-in-kind and added to the principal amount of the Term Loan Agreement, the First Incremental Loan and the Second Incremental Loan.
On March 12, 2025, we entered into the 2025 Amendment, pursuant to
which the 2025 Term Loan Lenders (as defined in the 2025 Amendment) agreed to provide us with an incremental term loan of $19.0 million.
The 2025 Amendment also amended the Amended and Restated Credit Agreement to (i) provide for an additional term loan from the 2025 Term
Loan Lenders in an aggregate amount not to exceed $20.0 million, subject to the approval of the Required Lenders in their discretion,
(ii) provide for the payment of substantial make-whole payments in the event we prepay the loans prior to their maturity, and (iii) provide
that the incremental term loan will be senior in right of repayment to the initial term loan.
In connection with the 2025
Amendment, we issued to the 2025 Lenders the
2025 Warrants to purchase 6.2 million shares of our ClassCommon AStock. Each 2025 Warrant entitles the registered holder to purchase one share
of our Common Stock .at Thea 2025price Warrantsof have$1.50 the
sameper termsshare, assubject theto 2024adjustment Warrants,with excepta thatfloor theyof $0.6979 and expire on March 12, 20352035. The 2025
Warrants contain certain provisions that do not meet the criteria for equity classification and certaintherefore adjustmentswere torecorded as liabilities.
The liability for the exercise2025 priceWarrants arewas subjectrecorded to
at a floorfair value of $0.6979.$5.4 million on the date of issuance with the offset included in debt
issuance costs.
In connection with the Second 2025 Amendment, we issued to the 2025 Lenders the 2025 Additional Warrants to purchase 6.6 million shares of our Common Stock. Each 2025 Additional Warrant entitles the registered holder to purchase one share of our Common Stock at a price of $1.50 per share, subject to adjustment with a floor of $0.6979 and expire on March 12, 2035. The liability for the 2025 Additional Warrants was recorded at a fair value of $5.4 million on the date of issuance with the offset included in debt issuance costs.
In connection with the SGI Agreement, we issued to SGI, the SGI Warrants to purchase 8.0 million shares of our Common Stock at a strike price of $1.50 per share. The SGI Warrants include full-ratchet anti-dilution protections, subject to a floor of $0.6979 with respect to adjustments to the exercise price and expire on March 12, 2035. The liability for the 2025 Additional Warrants was recorded at a fair value of $6.5 million on the date of issuance with the offset recorded as an asset to be amortized as a reduction of revenue over the life of the SGI Agreement.
A holder of the warrants will not have the right to exercise them, to the extent that after giving effect to such exercise, the holder (together with its affiliates) would beneficially own in excess of 49.9% of the shares of Common Stock outstanding immediately after giving effect to such exercise.
The warrant liability is subsequently re-measured to fair value at each reporting date with changes in the fair value included in earnings. During 2025, we recognized a gain of $17.2 million in our consolidated statement of operations for a decrease in the fair value of the warrants outstanding at December 31, 2025.
In connection with the issuance
of the Warrants, we entered into the Registration
Rights Agreement with holders of the Warrants (the “Holders”), providing
for the registration of Registrable Securities,Securities (as
defined in the Registration Rights Agreement), subject to customary terms and conditions. We are responsible for the payment of the Holders’
expenses in connection with any offering or sale of Registrable Securities by the Holders, including underwriting discounts or selling
commissions, placement agent or broker fees or similar discounts, commissions or fees relating to the sale of certain Registrable Securities.
In connection with the issuance of the 2025 Warrants, on March 12, 2025, we entered into a Second Amended and Restated Registration Rights Agreement (the “2025 Registration Rights Agreement”) with CCP, Blackwell, and Coliseum Capital Co-Invest III, L.P., (the “2025 Holders”), providing for the registration under the Securities Act of the 2025 Warrants, the shares issuable upon the exercise of the 2025 Warrants, other warrants held by the 2025 Holders (and shares issuable upon exercise thereof) and the Common Stock held by the 2025 Holders as of such date (the “2025 Registrable Securities”), subject to customary terms and conditions.
In connection with the issuance of the 2025 Additional Warrants, on May 2, 2025, we entered into a Third Amended and Restated Registration Rights Agreement (the “Third Amended Registration Rights Agreement”) with the 2025 Holders, providing for the registration under the Securities Act of the 2025 Additional Warrants, the shares issuable upon the exercise of the 2025 Additional Warrants, other warrants held by the 2025 Holders (and shares issuable upon exercise thereof) and the Common Stock held by the 2025 Holders as of such date (the “2025 Additional Registrable Securities”), subject to customary terms and conditions.
In connection with the issuance of the SGI Warrants, on May 2, 2025, we entered into a Registration Rights Agreement (the “SGI Registration Rights Agreement” and collectively with the 2025 Registration Rights Agreement and the Third Amended Registration Rights Agreement, the “Registration Rights Agreements”) with SGI, providing for the registration under the Securities Act of the SGI Warrants, the shares issuable upon the exercise of the SGI Warrants, and the Common Stock held by SGI as of such date (the “SGI Registrable Securities” and collectively with the 2025 Registrable Securities and 2025 Additional Registrable Securities, the “Registrable Securities”), subject to customary terms and conditions.
The Registration Rights Agreements entitle the investors party thereto to demand registration of the Registrable Securities and also to piggyback on the registration of Company securities by us and other Company securityholders. We will be responsible for the payment of the investors’ expenses in connection with any offering or sale of Registrable Securities, including underwriting discounts or selling commissions, placement agent or broker fees or similar discounts, commissions or fees relating to the sale of certain Registrable Securities.
The registration statement filed on May 23, 2025, which registered the Registrable Securities, was declared effective by the SEC on May 30, 2025.
On June 27, 2024, our Board
of Directors (“Board”) adoptedadopted, and we entered intointo, a limited-duration
stockholder rights agreement (the “NOL Rights
Plan”) with a stated expiration date of June 30, 2025. Our Board approved the
NOL Rights Plan to protect stockholder value by attempting
to safeguard our ability to use our June 30, 20242024, estimated $238 million of
net operating losses (the “Current NOLs”) to reduce
potential future federal income tax obligations from becoming substantially
limited by future ownership of our commonCommon stock.Stock. Upon adopting
the NOL Rights Plan, 0.3 million shares of our authorized shares of preferred
stock were designated as Series C Preferred Shares. Pursuant
to the NOL Rights Plan, our Board authorized and declared a dividend of one
right for each outstanding share of commonCommon stockStock to stockholders
of record at the close of business on July 26, 2024. Upon a stockholder
acquiring greater than a 4.9% ownership percentage threshold (or,
if a stockholder has beneficial ownership of in excess of 4.9%, then
the ownership percentage that is one-half of one percentage point
greater than their current beneficial ownership percentage), the rights
will become exercisable to significantly dilute any stockholder
who violates the ownership limitations of the NOL Rights Plan. The NOL
Rights Plan was ratified at a special meeting of our stockholders
on October 15, 2024 (the “Special Meeting”). TheOn May 6, 2025,
the Board accelerated the termination of the NOL Rights Plan willand automaticallythe expireNOL byProtective itsCharter termsAmendment, onto JuneMay 30,7, 2025.
In connection with the NOL
Rights Plan, our Board adopted a NOL Protective
Charter Amendment that adds an additional layer of protection to our Current NOLs until
June 30, 2025 by voiding any transfer of common stockCommon
Stock that results in a stockholder acquiring beyond a 4.9% ownership percentage threshold
(or, if a stockholder has current beneficial
ownership of in excess of 4.9%, then the ownership percentage that is one-half of one percentage
point greater than their current beneficial
ownership percentage). The NOL Protective Charter Amendment was approved by our stockholders
at the Special Meeting. TheOn May 6, 2025,
the Board accelerated the termination of the NOL Rights Plan and the NOL Protective Charter Amendment willto automaticallyMay expire by its terms on June 30,7, 2025.
We regularlyhave engageengaged in dialogue
with marketmultiple
parties participantsabout regardinga potentialbroad businessrange combinations,of partnershipsopportunities andto maximize shareholder value, including, but not limited to, a merger, sale or other strategic
or alternatives.financial Basedtransaction. on certain recent
preliminary inquiries, theThe Board has formed a special committee of independent directors and we have engaged a financial advisor to
support support
them in evaluating anya indicationsrange of interestoptions and exploring other potential strategic alternatives. If we are unsuccessful in engaging
in a favorable strategic alternative, then our ability to grow our business and compete with larger, including combined, competitors may
be adversely affected.
Impact of United States Tariff Policy
We continue to actively manage the impact of recent United States tariff policies. Importantly, all of our mattresses are manufactured in the United States, and about 15% of our cost of goods is tied to products sourced from overseas. This limited exposure is primarily concentrated in the textile side of the business, which includes sheets and mattress covers, but also includes the import of bases and foundations. Tariffs impacted us by approximately $9.1 million in 2025 due to our mitigation efforts which have reduced the overall impact to our initial expectations. While future changes in tariffs are difficult to predict, we currently estimate the total cost exposure in 2026 to be $7.7 million. We have shifted sourcing outside of China, and in July 2025, we implemented price increases on select products, including two mattress models. The tariff landscape remains fluid, and we are actively evaluating sourcing alternatives and pricing strategies on a case-by-case basis. We believe that our vertically integrated model and strong vendor relationships give us the flexibility to remain agile and responsive to changes in tariff policies, and we believe that we will be able to mitigate these impacts through a combination of supply chain repositioning, vendor collaborations, and selective pricing actions.
Net revenues decreased $22.7 $19.2
million, or 4.4%,3.9%, to $468.7 million in 2025 compared to $487.9 million in
2024 compared to $510.5 million in 2023.2024. This decrease was primarily driven by the industry-wide
demand softness for home-related products
coupled withand a reductionsoftness in advertisingthe spende-commerce tochannel, focuspartially onoffset moreby profitablegrowth marketing.in our Mattress Firm and
Costco programs. From a sales channel perspective in 2024,2025, e-commerce
DTC net revenues decreased $17.3$22.3 million, or 7.7%,7.9%, and wholesale net revenues
increased $3.2 million, or 1.6%, as compared to 2024. Within DTC in 2025, e-commerce net revenues decreased $23.4 million, or 11.4%, while
Purple showroom net revenues increased $4.3$1.1 million, or 5.8% and wholesale net revenues
decreased $9.6 million, or 4.5%,1.5%, as compared to 2023.2024. The growth in our wholesale revenues was due primarily
to our agreement with Mattress Firm as we expanded the number of stores and slots and the expansion of our Costco program. Purple showroom
increase netin revenues was primarily due to an increase in average
selling prices related to both strategic price adjustments and a sizeable
shift in product mix to our higher priced Rejuvenate Products.
Net revenues also benefited in 2024 from a full year’s impact of five new Purple showrooms that opened in 2023. In addition to demand
softness, our wholesale channel net revenues were negatively impacted in 2024 by intentionally exiting our relationship with certain customers.products.
Gross profit increased $7.4 million, or 4.1%, to $188.6 million in 2025 compared to $181.1 million in 2024 and our gross profit percentage improved to 40.2% in 2025 from 37.1% in 2024. The increase in gross profit is due mainly to the completion of our Restructuring Plan, as we had fewer costs this year, continued improvement in lowering material costs, improved operating efficiency and the recent actions to reduce our cost of warranty returns.
Operating expenses decreased $41.7 million, or 15.3% to $231.6 million in 2025 compared to $273.3 million in 2024. This decrease was driven by a $24.5 million decrease in restructuring, professional fees and other costs related to our restructuring and other cost reduction efforts, a $15.2 million decrease in employee related expenses and a $9.1 million decrease in advertising spend, partially offset by $7.1 million increase in strategic alternative costs.
Gross profit increased $9.3
million, or 5.4%, to $181.1 million in 2024 compared to $171.8 million in 2023 and our gross profit percentage improved to 37.1% in 2024
from 33.7% in 2023. These increases reflected improved production effectiveness in 2024 coupled with the negative impact in 2023 of non-recurring
costs associated with the transition to our new product lineup. The improved production effectiveness in 2024 was largely attributable
to supply chain initiatives and operational efficiency improvements implemented over the last 12 months. Gross profit and the related
percentage were both negatively impacted by $15.4 million of charges recorded pursuant to the Restructuring Plan. Although $1.6 million
of additional restructuring related charges are projected to be recorded in cost of revenues through the second quarter of 2025, we expect
the Restructuring Plan will further streamline our manufacturing operations and provide increased gross profits going forward.
Operating expenses decreased
$12.2 million, or 4.3% to $273.3 million in 2024 compared to $285.5 million in 2023. This decrease was driven by an $11.1 million decrease
in marketing and sales costs due primarily to a decline in advertising spend, a $15.3 million decrease in general and administrative expense
due largely to non-recurring legal and professional costs incurred by the Board’s special committee in 2023 and a $6.9 loss on impairment
of goodwill recorded in 2023. This decrease was offset in part by $20.0 million in charges related to the Restructuring Plan.
Other expense, net wasincreased
by $5.9
$2.4 million, or 41.4% to $8.3 million in 20242025 compared to $7.5$5.9 million in 2023.2024. OtherThis expense,increase netwas due primarily to an $11.3 million
increase in 2024 included interest expense of $17.5 million associated primarily
with the Related Party Loan, offseta reduction of $11.6 million in part by other income of $11.5 million related to
two twoinsurance payments received in 2024 for full settlement of a
previously filed business interruption claim.claim, partially offset by an
increase of $13.7 million in the gain on the change in fair value of the warrant liabilities and a $6.8 million reduction in all other
expenses.
Net loss attributable to Purple
Inc. was $97.9$51.4 million in 20242025 compared to a net loss of $120.8$97.9 million in 2023.2024. The $22.9$46.5 million decreaseimprovement in net loss was primarily
due to a $9.3$41.7 million decrease in operating expenses and a $7.4 million increase in gross profitprofit, partially offset by a $2.6 million
increase in all other expenses and a $12.2 million decrease in operating expenses. Excluding the impact of the $35.4 million
in restructuring, impairment and other related charges recorded in 2024, gross profit would have increased $24.7 million and operating
expenses would have decreased $32.2 million.offsets.
Our accompanying audited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liabilities in the normal course of business. Our audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should we be unable to continue as a going concern.
The recurring losses, working capital deficiency, the need for capital to fund our operations and the amount of cash reserves are factors that raise substantial doubt about our ability to continue as a going concern for the twelve-month period from the date the audited consolidated financial statements are made available. See Note 2 – Liquidity and Going Concern to our audited consolidated financial statements for the year ended December 31, 2025, included elsewhere in this Annual Report for additional information on our assessment.
We have taken decisive actions over the last year to build a more durable business that we believe is positioned for consistent, profitable growth. The fruits of these efforts are demonstrated by the strength of our recent results. We have also extended our debt maturities to April 2027, demonstrating the support of our lenders and providing additional runway and financial flexibility. Successful execution of our Path to Premium Sleep strategy and cost savings initiatives in 2025 resulted in strong revenue growth, margin expansion, and profitability levels we haven’t seen since 2021, and we believe we have a clear plan in place to build on this momentum in the year ahead. We anticipate that these factors will continue to support further improvements in our business, including strengthening long-term liquidity. From this strong foundation, we expect to continue to deliver results.
The way we think about the business today is fundamentally different than a year ago. Last year was about reshaping the business for a tougher market – right sizing our cost structure, strengthening the foundation and restoring profitability. Now, we are focused on growth with our strategic focus areas that build on what is already working and how we are running our business. We believe we are well positioned to grow our business given our new grid innovation, evolved messaging strategy, our new cost structure and other cost saving initiatives. Our Path to Premium Sleep strategy remains focused on the following three priorities to drive growth:
We believe, given the Restructuring
Plan and our new grid innovation, that we are well positioned to grow our business in this challenging market. We are focused on the following
three key initiatives to drive sustainable and profitable market share:
Our revenue recognition accounting
methodology contains uncertainties
because it requires management to make assumptions and to apply judgment to estimate the amount and
timing of future sales returns, uncollectible
accounts and variable consideration. Our estimates of the amount and timing of sales returns,
uncollectible accounts and variable consideration
are based primarily on historical trends, product return rates and current contract
terms. Accrued sales returns increaseddecreased from $5.4$6.5 million
at December 31, 20232024 to $6.5$4.5 million as of December 31, 2024.2025. Our allowance for
credit losses increaseddecreased from a$1.1 de minimis amountmillion at December
31, 20232024 to $1.1$0.4 million as of December 31, 2024.2025. We do not believe there is a reasonable
likelihood that there will be any material changes
in our accounting methodology, future estimates or assumptions used to measure our
estimated liability for sales returns and exchanges,
our allowance for credit losses or variable consideration. However, if actual results
are not consistent with our estimates or assumptions,
we may be exposed to losses or gains that could be material.
Impairment
We review our long-lived assets
and definite-lived intangible assets for impairment as of December 31 and whenever events or changes in circumstances indicate
the carrying amount may not be recoverable. If there are any indications of impairment, we perform a recoverability test by comparing
the carrying value of the assets to the estimated future cash flows (undiscounted and without interest charges - plus proceeds expected
from disposition, if any). If the estimated undiscounted cash flows are less than the carrying value of the assets, the Company calculates
an impairment loss. The impairment loss calculation compares the carrying value of its assets to the assets’ estimated fair value.
When the Company recognizes an impairment loss, the carrying amount of the impaired assets are reduced to estimated fair value based on
discounted cash flows, quoted market prices or other valuation techniques. Assets to be disposed of are reported at the lower of the carrying
amount of the asset or fair value less costs to sell. Cash flow models are reliant on various assumptions, including projected business
results and long-term growth factors. The Company determined there were indicators of impairment that existed at December 31, 2024 and
a recoverability test was required. Based on the results of this recoverability test, the Company concluded its long-lived and definite-lived
assets were not impaired as of December 31, 2024 and no resultant impairment charges were recorded.
In conjunction with the Restructuring
Plan initiated by us in August 2024, we recorded impairment charges of $2.5 million on various long-lived assets associated with entering
into a sublease on one of the Utah manufacturing facilities that is expected to close during the first quarter of 2025.
The Restructuring Plan initiated
by us in August 2024 was determined to be a triggering event for potential impairment of intellectual property that was being accounted
for as an indefinite-lived intangible asset. The resultant impairment assessment performed by us determined this asset no longer had any
supportable value and an $8.5 million impairment charge to write off the entire balance of the asset was recorded in 2024.
We provide a limited warranty
on most of the products we sell. Our warranty liability assessment methodology includes estimates in both our DTC and wholesale channels.
The estimated warranty costs associated with products sold through DTC channels are expensed at the time of sale and included in cost
of revenues. The estimated warranty costs associated with products sold through the wholesale channel are recorded at the time of sale
and included as an offset to net revenues. Estimates for DTC warranty costs are based primarily on historical trendswarranty claims, estimated
warranty costs and the estimated warranty claim ratesrate. Estimates for wholesale warranty costs are based primarily on the historical warranty
incurred.claim amounts and the estimated warranty claim rate. We regularly assess and may adjust the estimate of accrued warranty claims by updating claims rates for any
current or expected
trends and changes in projected claim costs. We expect the estimated warranty liability to continue to increase as
we have not yet reached
the full 10 years of history on our 10-year mattress warranty. We classify as non-current those estimated warranty
costs expected to be
paid out in greater than one year. As of December 31, 2024,2025, the current and non-current portions of
our warranty liabilities
were $7.1 million and $19.6 million, respectively, compared to $6.1 million and $26.1 million, respectively, compared to $9.8 million and $25.8 million, respectively,
at December 31, 2023.
2024. We do not believe there is a reasonable likelihood that a material change in the estimates or assumptions we use
to calculate our warranty
liability will occur. However, if actual results are not consistent with our estimates or assumptions, we may
be exposed to losses or
gains that could be material.
Net revenues decreased $19.2 million, or 3.9%, to $468.7 million in 2025 compared to $487.9 million in 2024. This decrease was primarily driven by the industry-wide demand softness for home-related products and softness in the e-commerce channel, partially offset by growth in our Mattress Firm and Costco programs. From a sales channel perspective in 2025, DTC net revenues decreased $22.3 million, or 7.9%, and wholesale net revenues increased $3.2 million, or 1.6%, as compared to 2024. The growth in our wholesale revenues was due primarily to our agreement with Mattress Firm as we expanded the number of stores and slots and expansion of our Costco program, partially offset by the decrease in wholesale door count in 2024. Within DTC in 2025, e-commerce net revenues decreased $23.4 million, or 11.4%, while Purple showroom net revenues increased $1.1 million, or 1.5%, as compared to 2024.
What changed in the latest 10-Q
Risk Factors
New heading “Risks Relating to our Common Stock”
New heading “Nasdaq may delist our securities from its exchange, which could harm our business and limit our stockholders’ liquidity.”
Largest changes
“Nasdaq may delist our securities from its exchange, which could harm our business and limit our stockholders’ liquidity.”see in full comparison
“If we are unable to comply with Nasdaq’s continued listing requirements, our common stock may be subject to delisting. …”see in full comparison
“Our common stock is currently listed on Nasdaq, which has listing criteria. We cannot assure that our common stock will continue to be listed on Nasdaq in the future. To continue listing our common stock on Nasdaq, we must maintain certain governance, financial, distribution and stock price levels. Generally, we must maintain a minimum amount in stockholders’ equity, a minimum number of holders of our common stock, and a $1.00 minimum per share bid price for our common stock. …”see in full comparison
Full comparison: every changed paragraph (5)
The
Company’s business, reputation, results of operations, financial condition and stock price can be materially and adversely affected
by a number of factors, whether currently known or unknown, including those described below and in Part I, Item 1A of the 2025 Annual Report on
Form 10-K filed with the SEC on March 31, 2026 under the heading “Risk Factors.” There have been no material changes
from the risk factors previously disclosed in our 2025 Annual Report on Form 10-K filed with the SEC on March 31, 2026.2026, except as set forth below.
Risks Relating to our Common Stock
Nasdaq may delist our securities from its exchange, which could harm our business and limit our stockholders’ liquidity.
Our common stock is currently listed on Nasdaq, which has listing criteria. We cannot assure that our common stock will continue to be listed on Nasdaq in the future. To continue listing our common stock on Nasdaq, we must maintain certain governance, financial, distribution and stock price levels. Generally, we must maintain a minimum amount in stockholders’ equity, a minimum number of holders of our common stock, and a $1.00 minimum per share bid price for our common stock. We have in the past experienced, and may experience in the future, noncompliance with Nasdaq’s continued listing requirements. While we are currently in compliance with the continued listing requirements, we cannot guarantee that we will be able to maintain such compliance in the future.
If we are unable to comply with Nasdaq’s continued listing requirements, our common stock may be subject to delisting. If Nasdaq delists our common stock from trading on its exchange or if we decide to voluntarily delist from Nasdaq and/or deregister our common stock under the federal securities laws, we could face significant material adverse consequences, including but not limited to (i) a limited availability of market quotations for our common stock; (ii) reduced liquidity for our common stock; (iii) a determination that our common stock is a “penny stock” which will require brokers trading in our common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; (iv) a limited amount of news and analyst coverage, and in the event of deregistration of our common stock, less public disclosure about us; and (v) a decreased ability to issue additional securities or obtain additional financing in the future.
Management's Discussion & Analysis (MD&A)
New heading “Reclassification of Merchant and Financing Fees”
New heading “Pricing Actions”
New heading “Reverse Stock Split”
New heading “Operating Results for the Six Months Ended June 30, 2026, and 2025”
New heading “Total Cost of Revenues”
New heading “Marketing and Sales”
New heading “General and Administrative”
New heading “Research and Development”
New heading “Restructuring, Impairment and Other Related Charges”
New heading “Interest Expense”
New heading “Change in Fair Value – Warrant Liabilities”
New heading “Income Tax (Expense) Benefit”
New heading “Noncontrolling Interest”
Largest changes
“Debt service has consisted primarily of re-financing or extending the maturity date of the debt as well as paying-in-kind interest payments. As disclosed in Note 10 - Debt, the Company has elected to have interest paid-in-kind and added to the principal amount of the loans under the Amended and Restated Credit Agreement and on March 24, 2026, the Company executed the Third Amendment to the Amended and Restated Credit Agreement (the “Third Amendment”) with the Lenders to extend the maturity date of the Amended and Restated Credit Agreement from December 31, 2026 to April 30, 2027. …”see in full comparison
“Restructuring, Impairment and Other Related Charges”see in full comparison
“Total cost of revenues decreased $11.7 million, or 9.7%, to $109.4 million for the six months ended June 30, 2026, compared to $121.1 million for the six months ended June 30, 2025. This decrease was due primarily to a $5.3 million credit for tariff refunds we received in the second quarter, costs of $5.4 million to a manufacturer under common control that were booked against revenues, $3.0 million in lower tariff payments and a $1.0 million reduction in restructuring costs as the plan ended in 2025. …”see in full comparison
“Operating loss decreased $7.6 million, or 26.5%, to $21.1 million, for the six months ended June 30, 2026, compared to $28.7 million for the six months ended June 30, 2025. This decrease in our operating loss is the result of the reduced marketing and sales expenses and no restructuring and impairment charges in 2026, partially offset by reduced gross profit due to lower revenues and increases in other operating expenses.”see in full comparison
see in full comparisonWeThehaveCompany has taken a number of actions to increase cash flow and supportourits operations and strategies. In August 2024,wethe Company implemented the Restructuring Plan(as defined below)to consolidate manufacturing operations resulting in cost savings.WeThehaveCompany has realized andplanplans to continue to realize direct material cost savings by concentrating efforts on driving gross margin improvement through various methods such asselectivepricing actions, continued mix shift towards the Restore and Rejuvenate collections, and by driving cost savings through supply chain initiatives and manufacturing efficiency.WeThehaveCompany has delivered direct material cost savings fromourits supplier diversification efforts, improved scrap and yield results from continuous improvements, and outbound freight costs reflect cost improvements along with improved delivery reliability.WeThehaveCompany has been successful in subleasing the two manufacturing facilities that were vacated as part of the Restructuring Plan.WeThehaveCompany has also taken additional cost-saving initiatives in 2025 and the beginning of 2026 to reduce headcount and streamline responsibilities and reporting structure. Further,ourmanagement’s plans include additional actions intended to improve liquidity and reduce costs, including a planned optimization of advertisingspend,limitingspending, pacing the number of new store openings, efforts to mitigate tariff impacts by managing the country of origin, and other cost-saving initiatives.WeInhavetheelectedlatter part of the second quarter of 2026, the Company announced a pricing action tohaveincreaseinterestthepaid-in-kindsales price of our various products to offset the impact of materials andaddedlogistics inflation related to theprincipal amountrise ofthefuelloans under the Amendedprices andRestated Credit Agreement. On March 24, 2026, we executed the Third AmendmenttothemaintainAmendedgrossandmargins.RestatedTheCreditCompanyAgreement (the “Third Amendment”) with the Lenders to extend the maturity date of the Amended and Restated Credit Agreement from December 31, 2026 to April 30, 2027. We areis currently evaluating potential strategic alternatives and opportunities to achieve additional liquidity through one or more future debt refinancings.
“The funds we have on hand and any follow-on capital, if needed, will be used to fund our operations and invest in the business to expand sales and marketing efforts, as well as to invest in innovation. As described below, we have implemented plans that we believe will both increase our revenues from the sales of our products and achieve cost savings within the next year, sufficient to generate positive operating cash flow levels. However, we may be adversely impacted by uncertain market conditions and there can be no assurance that we will be successful in this regard. …”see in full comparison
Full comparison: every changed paragraph (74)
We caution and advise readers that these statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict, including those included in the “Risk Factors” section of this Quarterly Report and in our Annual Report on Form 10-K filed with the SEC on March 31, 2026 and our Quarterly Report on Form 10-Q filed with the SEC on April 28, 2026. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements and investors are cautioned not to place undue reliance on any such statements. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
We began as a digitally-native
digitally native vertical brand founded on comfort product innovation with premium offerings, and have since expanded into brick & mortar stores as
a true omni-channel brand. We offer a variety of innovative, branded and premium comfort products, including mattresses, pillows, cushions,
bases, sheets and more. Our products are the result of decades of innovation and investment in proprietary and patented comfort technologies
and the development of our own manufacturing processes. Our proprietary Hyper-Elastic Polymer gel technology underpins many of our comfort
products and provides a range of benefits that differentiate our products from our competitors. Specially engineered to relieve pressure,
maintain an ideal body temperature, and provide instantly adaptive support, Purple’s patented technology has been tested rigorously
within medical and consumer applications for over 30 years. Originally designed for use in hospital beds and wheelchairs, we adapted this
unique pressure-relieving material for our mattresses, pillows and other cushion products.
Our business consists of Purple
Inc. and its consolidated subsidiary, Purple LLC. As the sole managing member of Purple LLC, Purple Inc., through its officers and directors,
is responsible for all operational and administrative decision making and control of the day-to-day business affairs of Purple LLC without
the approval of any other member. At MarchJune 31,30, 2026, Purple Inc. had a 99.85% economic ownership interest in Purple LLC while Class B
unit holders had the remaining 0.15%.
We continue building on the progress we made in the past year and remain focused on where we believe we can make the most impact. The demand environment remained challenging in the second quarter of 2026, and we made progress in our showroom and E-commerce channels. Our showroom business was up 16.6% compared to last year. This was driven by improving traffic, stronger conversion and strength in our premium products. E-commerce was down slightly by 1.4% compared to last year, but we are moving in the right direction as we have had three consecutive quarters of sequential improvement. We are improving our management of the channel and the work we are doing across marketing and the website experience is contributing to that progress. Our performance in the wholesale channel remained challenged as revenues were down 19.1% compared to last year. This decrease is due to certain payments to customers and a manufacturer under common control with a customer which represent consideration paid to a customer and are recorded as a reduction of revenue. In addition, we experienced lower wholesale sales volumes related to lower industry demand. Operationally, we continue to see the benefits of previous actions taken in areas we can control, reflected in our improved profitability and cash generation, disciplined expense performance and inventory management. We continue to invest in innovation, advertising and consumer experience. Although the demand environment remains uncertain, we believe that we are operating from a stronger foundation. We expect to benefit from continued operational improvements, additional sourcing initiatives and the continued development of our premium product line.
We entered 2026 building
on the progress we made in the fourth quarter, and our first quarter reflects continued progress and greater consistency across our
channels. Trends were solid during the quarter, with growth in our showroom and wholesale channels. The E-commerce channel also
improved sequentially declining 10% in the first quarter year over year compared to down 15% in the prior period year over year,
reflecting more disciplined marketing execution and early signs of improved conversion. Importantly, we continue to see the benefits of actions taken last year reflected in our operating expense
performance. This progress is a direct result of the changes we’ve made to the business, not a recovery of the broader market,
reinforcing the durability of the model we’ve been building.
Revenue for certain product
arrangements is presented differently depending on the nature of the underlying manufacturing relationships and the application of ASC
606—Revenue from Contracts with Customers. Under the guidance, payments to third-party manufacturers, including manufacturers
under common control with certain customers, are evaluated to determine whether they are economically linked to an underlying customer
arrangement. For certain customer-specific or exclusive product programs where the manufacturer is under common control with the customer,
the Companywe hashave concluded that payments to the manufacturer are economically linked to the customer relationship and therefore represent
consideration payable to a customer. As a result, these payments are recorded as a reduction of revenue, and revenue is presented on a
net basis. The CompanyWe recorded $4.9$0.5 million and $5.4 million in consideration paid as a reduction of revenue in the unaudited condensed consolidated statement
of operations for the three months and six months ended MarchJune 31,30, 2026.2026, respectively. This presentation results in reported revenue being lower than the gross amount
billed to the customer. While the net presentation affects reported revenue, it does not impact gross profit dollars for these arrangements.
The distinction reflects the application of GAAP to different fact patterns rather than a difference in the underlying economics of the
transactions.
On March 24, 2026, the Loan Parties entered into the Third Amendment with the Lenders, which revised the maturity date under the Amended
A&R Credit Agreement from December 31, 2026, to April 30, 2027 and waived certain requirements and events of default relating to the
going concern qualification in our December 31, 2025 financial statements. In connection with the Third Amendment, the Loan Parties agreed
to pay to the Lenders an amendment fee in the aggregate amount of $1.6 million, equal to 1.25% pro rata based on each Lender’s outstanding
principal amount (the “Amendment Fee”). Of the Amendment Fee, approximately $1.3 million iswas payable-in-kindpaid-in-kind by adding such
amount to the 2025 Lenders’ outstanding principal amount. The remaining $0.3 million of the Amendment Fee was paid in cash to the
other lenders. In connection with the Third Amendment, the Loan Parties also agreed to reimburse the 2025 Lenders for certain expenses
in the amount of $0.3 million.
Reclassification of Merchant and Financing Fees
In the second quarter of 2026, we changed the presentation of costs associated with merchant credit card processing fees and third-party consumer financing fees. These costs were previously presented within cost of revenues and are now presented within marketing and sales. We believe this presentation will enhance the comparability of our financial statements with those of our industry peers.
The tables below present the effect of the reclassification on our previously issued financial statements. This change in presentation had no impact on previously reported revenues, operating loss, net loss, or earnings per share. Additionally, the reclassifications did not impact the historical balance sheets or statement of cash flows.
We continue to actively manage the impact of recent United States tariff
policies. Importantly, all of our mattresses are manufactured in the United States, and about 15% of our cost of goods is tied to products
sourced from overseas. This limited exposure is primarily concentrated in the textile side of the business, which includes sheets and
mattress covers, but also includes the import of bases and foundations. Tariffs impacted us by approximately $1.0$0.9 million and $1.8 million during the three
and six months ended MarchJune 31,30, 20262026, respectively, due to our mitigation efforts which have reduced the overall impact to our initial expectations. The tariff
landscape remains fluid, and we are actively evaluating sourcing alternatives and pricing strategies on a case-by-case basis. We believe
that our vertically integrated model and strong vendor relationships give us the flexibility to remain agile and responsive to changes
in tariff policies, and we believe that we will be able to partially mitigate these impacts through a combination of supply chain repositioning,
vendor collaborations, and selective pricing actions. On March 6, 2026, we filed a lawsuit in the U.S. Court of International Trade against
the U.S. Customs and Border Protection (“CBP”), the CBP commissioner, and the United States of America seeking a full refund
of the $5.3 million in tariffs imposed under the International Emergency Economic Powers Act that the Company has paid to the United States
States. During the second quarter of 2026, we received $5.5 million in tariff refunds plus interest (See Note 132 – CommitmentsSummary andof Contingencies,Significant LegalAccounting ProceedingsPolicies, Refund of Tariffs).
Pricing Actions
In the latter part of the second quarter of 2026, we announced a pricing action to increase the sales price of our products across all products to offset the impact of materials and logistics inflation related to the rise of fuel prices and to maintain gross margins. We expect all price increases will be effective with all customers during the third quarter of 2026.
Reverse Stock Split
On July 2, 2026, our stockholders approved a reverse stock split of our Class A common stock and Class B common stock (collectively, the “common stock”) at a ratio ranging from any whole number between 1-for-10 to 1-for-30, with the exact ratio determined by the Company’s Board of Directors. On July 6, 2026, the Board of Directors approved a 1-for-25 reverse stock split (“Reverse Stock Split”) of the Company’s common stock that became effective on July 19, 2026. Following the effect of the Reverse Stock Split, every 25 shares of the Company’s common stock that were issued and outstanding automatically converted into one outstanding share of common stock. All stock awards and warrants of the Company outstanding immediately prior to the Reverse Stock Split were proportionally adjusted.
The Reverse Stock Split did not change the Company’s authorized number of shares of common stock. The Reverse Stock Split did not change the par value of the common stock and, therefore the Company reclassified an amount equal to the reduction in the number of shares of common stock at par value to additional paid-in capital. No fractional shares of common stock were issued in connection with the Reverse Stock Split. Instead, any fractional share that would otherwise result from the Reverse Stock Split will be rounded up to the next whole share of common stock. Proportionate adjustments were made to the number of shares authorized under the Company’s equity incentive plans, the number of shares subject to any award or purchase right under the Company’s equity incentive plans, and the exercise price or purchase price with respect to any stock award or warrant.
Net revenues decreased $6.8 million, or 6.5%, to $98.3 million for the three months ended June 30, 2026 compared to $105.1 million for the three months ended June 30, 2025. The decrease in revenue was primarily driven by an $8.8 million or 19.1% decrease in our wholesale revenue due to an increase of $5.3 million in certain payments to customers and a manufacturer under common control with a customer. These payments represent consideration paid to a customer and are recorded as a reduction of revenue. In addition, we had a $3.5 million decrease in wholesale sales volume related to lower industry demand. E-commerce net revenues also decreased $0.6 million, or 1.4%. While down against the prior year’s period, E-commerce net revenues for the three months ended June 30, 2026 represented the third quarter of sequential improvement. These decreases were partially offset by a $2.6 million or 16.6% increase in showroom net revenues which continues to outperform the mattress industry.
Net revenues decreased $8.4
million, or 8.1%, to $95.7 million for the three months ended March 31, 2026 compared to $104.2 million for the three months ended March
31, 2025. The drop in revenue was primarily due to a decrease in e-commerce sales and recognized wholesale revenue. From a sales channel
perspective, e-commerce net revenues decreased $4.8 million, or 10.6%, wholesale net revenues decreased $4.5 million or 11.0% and showroom
net revenues increased $0.9 million, or 4.8%. The decrease in wholesale revenue was due mainly to $4.9 million in payments to a manufacturer
that is under common control with a customer and represents consideration paid to a customer. Accordingly, these payments are recorded
as a reduction in revenue. The decreases were partially offset by our showroom net revenue increase of $0.9 million or 4.8%. The increase
in our showrooms channel represents a 7.0% year-over-year increase for all stores that have been open for 13 or more months. This is the
third consecutive quarter of year-over-year growth in the showrooms channel, driven by increased order values through effective upselling
and product bundling.
Gross profit decreased
$5.9increased $1.9 million, or 14.3%,4.5%, to $35.2$44.4 million for the three months ended MarchJune 31,30, 2026 compared to $41.0$42.5 million for the three months
ended MarchJune 31,30, 2025. Our gross profit percentageincreased decreaseddue to 36.8%the $5.3 million benefit from tariff refunds, partially offset by lower sales. Our gross profit percentage increased to 45.2% of net revenues in the firstsecond quarter of 2026 from 39.4%40.5% in the
first second quarter of 2025 primarily due to our strategic investment in Purple Royale floor models to support the Mattresstariff Firm rollout, as well as
modest manufacturing overhead deleverage driven by lower production volumes and less favorable absorption of fixed costs.refund.
Operating expenses decreased $3.5$8.1 million, or 6.3%14.3% to $52.0 million
for the three months ended March 31, 2026 compared to $55.5$48.7 million for the three months ended MarchJune 31,30, 2026 compared to $56.8 million for the three months ended June 30, 2025. This decrease was driven
by a $3.3$4.1 million decrease in advertisingrestructuring spending,related costs from last year, a $2.8$4.0 million decrease in employee related expenses and $2.0$2.1 million decrease in
restructuring relatedprofessional costsservices fromand lastall year,other operating expenses, partially offset by $4.6a $2.1 million increase in strategicadvertising alternative and other costs.spending.
Total other expense,income (expense), net increasedwas $9.0$1.0 million,million ornet 194.6%other to $13.7
millionincome for the three months ended MarchJune 31,30, 20262026, compared to $4.6$3.1 million net other expense for the three months ended MarchJune 31,30, 2025. The other expense,
income, net infor the firstthree quartermonths ofended June 30, 2026 consists of interest expense of $8.2$7.4 million andgain afrom $7.0 million loss onthe change in the fair value of warrants,
partially offset by $1.5$1.4 million in other income.income, partially offset by $7.8 million in interest expense. The other expense, net in the firstthree quartermonths ofended June 30, 2025 consists of interest expense of
$4.8 $7.5 million, partially offset by $0.2$4.4 million in other income anddue to the gain on the change in the fair value of warrants.
Net loss attributable to Purple
Inc. was $30.5$3.2 million for the three months ended MarchJune 31,30, 2026 compared to a net loss of $19.1$17.3 million for the three months ended March
31,June 30, 2025. The $11.4$14.1 million increasedecrease in net loss was primarily due to lowerhigher grossmargins, marginsreduced operating expenses and the increase in lossgain from change in fair
value of the warrants, partially offset by reduced operating expenses.warrants.
There is no guarantee that we will be able to
effectively execute on these initiatives, which are subject to risks, uncertainties, and assumptions that are difficult to predict, including
the risks described in the “Risk Factors” section of this Quarterly Report and in our Annual Report on Form 10-K filed with
the SEC on March 31, 2026 and elsewhereour herein.Quarterly Report on Form 10-Q filed with the SEC on April 28, 2026. Therefore, actual results may differ materially and adversely from those described above.
In addition, we may, in the future, adapt these focuses in response to changes in the market or our business.
Operating Results for the Three Months Ended MarchJune 31,30, 2026 and
2025
Net revenues decreased $6.8 million, or 6.5%, to $98.3 million for the three months ended June 30, 2026 compared to $105.1 million for the three months ended June 30, 2025. The decrease in revenue was primarily driven by an $8.8 million or 19.1% decrease in our wholesale revenue due to an increase of $5.3 million in certain payments to customers and a manufacturer under common control with a customer. These payments represent consideration paid to a customer and are recorded as a reduction of revenue. In addition, we had a $3.5 million decrease in wholesale sales volume related to lower industry demand. E-commerce net revenues also decreased $0.6 million, or 1.4%. While down against the prior year’s period, E-commerce net revenues for the three months ended June 30, 2026 represented the third quarter of sequential improvement. These decreases were partially offset by a $2.6 million or 16.6% increase in showroom net revenues which continues to outperform the mattress industry.
Net revenues decreased $8.4
million, or 8.1%, to $95.7 million for the three months ended March 31, 2026 compared to $104.2 million for the three months ended March
31, 2025. This decrease was primarily driven by our e-commerce and wholesale recognized revenue. From a sales channel perspective, e-commerce
net revenues decreased $4.8 million, or 10.6%, wholesale net revenue decreased $4.5 million or 11.0% and showroom net revenues increased
$0.9 million, or 4.8%. The decrease in wholesale revenue was due mainly to $4.9 million in payments to a manufacturer that is under common
control with a customer and represents consideration paid to a customer. Accordingly, these payments are recorded as a reduction in revenue.
Total cost of revenues
decreased $2.6$8.7 million, or 4.1%,14.0%, to $60.5$53.9 million for the three months ended MarchJune 31,30, 2026, compared to $63.1$62.6 million for the three
months ended MarchJune 31,30, 2025.2026. This decrease was due primarily to $4.9a $5.3 million benefit from our tariff rebates that we received during the quarter, $2.3 million in costslower associatedtariff withpayments aand manufacturer$1.1 that is
affiliated with a customer recorded asmillion reduction ofin revenue.other This decrease was partially offset by less favorable absorption of
fixed costs from lower production volumes.costs. Our gross profit percentage decreasedincreased to 36.8%45.2% of net revenues in the firstsecond quarter of
2026 from 39.4%40.5% in the firstsecond quarter of 2025, due to our strategic investment in Purple Royale floor modelsmainly to support the Mattress
Firmtariff rollout, as well as modest manufacturing overhead deleverage driven by lower production volumes and less favorable absorption
of fixed costs.refund.
Marketing and sales expense decreased $5.1$1.7 million, or 13.8%,4.8%, to $31.6
million for the three months ended March 31, 2026 compared to $36.6$33.7 million for the three months ended MarchJune 31,30, 2026 compared to $35.4 million for the three months ended June 30, 2025. This decrease primarily
consisted of a $3.3$2.3 million decrease in advertisingvarious spend,marketing activities and professional services, a $1.3$1.2 million decrease in employee relatedemployee-related expenses due to head countheadcount reductions
and $0.2$0.3 million decrease in all other marketing and sales expenses.expenses, partially offset by a $2.1 million increase in advertising spending.
General and administrative expense decreased $2.5 million, or 17.0%, to $12.4 million for the three months ended June 30, 2026 compared to $15.0 million for the three months ended June 30, 2025. This decrease was due to a $2.7 million decrease in employee related costs due to headcount reductions and $0.5 million reduction in strategic alternative costs, partially offset by a $0.7 million increase in all other general and administrative costs.
General and administrative expense increased $3.5 million, or 24.5%,
to $18.0 million for the three months ended March 31, 2026 compared to $14.5 million for the three months ended March 31, 2025. This increase
was due to a $4.3 million increase in strategic alternative costs and an increase of $0.7 million in all other general and administrative
costs, partially offset by a $1.4 million decrease in employee related costs due to headcount reductions.
Research and development expense wasincreased flat$0.3 million, or 14.1%, to prior year at $2.4$2.5 million
for the three months ended MarchJune 31,30, 2026 compared to $2.2 million for the three months ended MarchJune 31,30, 2025. The increase is due to an increase in professional service expenses.
There were no restructuring,
impairment and other related charges for the three months ended MarchJune 31,30, 2026 as all restructuring activities were completed in 2025.
We incurred $2.0$4.1 million of restructuring, impairment and other related charges during the three months ended MarchJune 31,30, 2025.
Operating loss increaseddecreased $2.4
$9.9 million, or 16.3%,70.1%, to $16.8$4.3 million, for the three months ended MarchJune 31,30, 2026 compared to $14.5$14.2 million for the three months ended March
31,June 30, 2025. This increasedecrease in our operating loss is the result of a lowerhigher gross profit percentpercent, lower operating expenses and increasesno restructuring costs in strategic alternative costs,
partially offset by reduced advertising spend and lower headcount costs.2026.
Interest expense totaled $8.2
million for the three months ended March 31, 2026 compared to $4.8$7.8 million for the three months ended MarchJune 31,30, 2026 compared to $7.5 million for the three months ended June 30, 2025. This increase was
primarily due to additional interest incurred on a higher principal balance on the Related Party Loan as the Company elected the paid-in-kind
option on monthly interest over the past 12 months.months along with additional debt issuance costs to amortize over the life of the loan.
Other income increasedwas to
$1.5 million for the three months ended MarchJune 31,30, 2026 compared to $0.1a millionde minimis amount for the three months ended MarchJune 31,30, 2025. This increase
was mainly due to $1.3$1.2 million received for sublease rent payments on facilities we are no longer using and have subleased to other parties.
Our Warrantswarrants contain certain
provisions that did not meet the criteria for equity classification and therefore are recorded as liabilities with a re-measurement of
fair value at each reporting date. We incurred a $7.0$7.4 million lossgain on the change in fair value of our warrant liabilities for the three
months ended MarchJune 31,30, 2026 related to the increasedecrease in fair value from the previous reporting date.date, due mainly to the reduction in stock price. For the three months ended MarchJune 31,
30, 2025, we recognized a negligible$4.4 million gain related to the net decrease in fair value of the warrant liability.liability during that period.
We had a de minimis income
tax expense for the three months ended MarchJune 31,30, 2026 and 2025. The income tax expense amounts in both the firstsecond quarter of 2026 and 2025
were related to various state taxes.
We calculate net loss attributable
to noncontrolling interests on a quarterly basis using their weighted average ownership percentage. Net loss attributed to noncontrolling
interests was negligible for the three months ended MarchJune 31,30, 2026 and 2025.
Operating Results for the Six Months Ended June 30, 2026, and 2025
The following table sets forth for the periods indicated, our results of operations and the percentage of total revenue represented in our unaudited condensed consolidated statements of operations (dollars in thousands):
Revenues, Net
Net revenues decreased $15.3 million, or 7.3%, to $194.0 million for the six months ended June 30, 2026, compared to $209.3 million for the six months ended June 30, 2025. This decrease was primarily driven by a $13.3 million or 15.3% decrease in our wholesale revenue due to an increase of $11.1 million in certain payments to customers and a manufacturer under common control with a customer. These payments represent consideration paid to a customer and are recorded as a reduction of revenue. In addition, we had a $2.2 million decrease in wholesale sales volume related to lower industry demand. E-commerce net revenues decreased $5.4 million, or 6.1% and showroom net revenues increased $3.5 million, or 10.3%.
Total Cost of Revenues
Total cost of revenues decreased $11.7 million, or 9.7%, to $109.4 million for the six months ended June 30, 2026, compared to $121.1 million for the six months ended June 30, 2025. This decrease was due primarily to a $5.3 million credit for tariff refunds we received in the second quarter, costs of $5.4 million to a manufacturer under common control that were booked against revenues, $3.0 million in lower tariff payments and a $1.0 million reduction in restructuring costs as the plan ended in 2025. These costs were offset by a $3.0 million increase in material and other costs, primarily logistics due to higher fuel costs and reduced driver supply. Our gross profit percentage increased to 43.6% for the first six months in 2026 from 42.1% in the first six months of 2025.
Marketing and Sales
Marketing and sales expense decreased $6.4 million, or 8.3%, to $70.3 million for the six months ended June 30, 2026, compared to $76.7 million for the six months ended June 30, 2025. This decrease is due to a decrease of $2.6 million for payroll related costs, a decrease of $1.2 million in advertising spending, and a decrease of $2.6 million in all other marketing expenses.
General and Administrative
General and administrative expense increased $1.0 million, or 3.4%, to $30.5 million for the six months ended June 30, 2026, compared to $29.5 million for the six months ended June 30, 2025. This increase was primarily due to $3.8 million increase in strategic alternative costs, increase in facilities and other expenses of $1.3 million, partially offset by a $4.1 million decrease in employee related expenses due to headcount reductions.
Research and Development
Research and development expense increased $0.3 million, or 6.5%, to $4.9 million for the six months ended June 30, 2026, compared to $4.6 million for the six months ended June 30, 2025. This increase is due to an increase in professional services during the period.
Restructuring, Impairment and Other Related Charges
There were no restructuring, impairment and other related charges for the six months ended June 30, 2026 as all restructuring activities were completed in 2025. We incurred $6.1 million of restructuring, impairment and other related charges during the six months ended June 30, 2025.
Operating Loss
Operating loss decreased $7.6 million, or 26.5%, to $21.1 million, for the six months ended June 30, 2026, compared to $28.7 million for the six months ended June 30, 2025. This decrease in our operating loss is the result of the reduced marketing and sales expenses and no restructuring and impairment charges in 2026, partially offset by reduced gross profit due to lower revenues and increases in other operating expenses.
Interest Expense
Interest expense totaled $16.0 million for the six months ended June 30, 2026, compared to $12.2 million for the six months ended June 30, 2025. This increase was primarily due to additional interest incurred on a higher principal balance on the Related Party Loan as the Company elected the paid-in-kind option on monthly interest over the past 12 months.
Change in Fair Value – Warrant Liabilities
Our warrants contain certain provisions that did not meet the criteria for equity classification and therefore are recorded as liabilities with a re-measurement of fair value at each reporting date. We incurred a $0.4 million gain on the change in the fair value of our warrant liabilities for the six months ended June 30, 2026. For the six months ended June 30, 2025, we recognized a $4.4 million gain related to the decrease in fair value of the warrant liability during that period.
Income Tax (Expense) Benefit
We had a $0.1 million income tax expense for the six months ended June 30, 2026, compared to $0.1 million income tax expense for the six months ended June 30, 2025. The income tax expense amounts in the six months ended June 30, 2026 and 2025 were related to various state taxes.
PRPL insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 1 Form 4 filing (1 insider, 1 trade date, 60,000 shares, about $29.4K) and open-market sales in 0 filings. Net open-market shares: 60,000 (purchases minus sales); net value about $29.4K.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-04 | Lucian Robert Gerard |
Open-market purchase | 60,000 | $0.49 | $29.4K |
Well-known investors holding PRPL (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Millennium Management (Israel Englander) | 2026-06-30 | 727,895 | $259.9K | 0.0% | Reduced 14% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 64,822 | $42.9K | — | Sold out |
| Renaissance Technologies | 2026-06-30 | 43,477 | $15.5K | 0.0% | Reduced 94% |
| Point72 Asset Management (Steve Cohen) | 2026-06-30 | 13,612 | $9.0K | — | Sold out |